"","pdbid","title","method","molecule","代表構造"
"1","7JMW","CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING ANTIBODY COVA1-16 FAB","X-RAY DIFFRACTION (2.89 Å)","Spike protein S1, COVA1-16 heavy chain, COVA1-16 light chain, ...",TRUE
"2","6XKQ","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-250","X-RAY DIFFRACTION (2.55 Å)","Spike protein S1, CV07-250 Heavy Chain, CV07-250 Light Chain, ...",TRUE
"3","7JX3","MAPPING NEUTRALIZING AND IMMUNODOMINANT SITES ON THE SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BY STRUCTURE-GUIDED HIGH-RESOLUTION SEROLOGY","X-RAY DIFFRACTION (2.65 Å)","Light chain of Fab domain of monoclonal antibody S309, Heavy chain of Fab domain of monoclonal antibody S309, Light chain of Fab domain of monoclonal antibody S2H14, ...",TRUE
"4","6XKP","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270","X-RAY DIFFRACTION (2.72 Å)","Spike protein S1, CV07-270 Heavy Chain, CV07-270 Light Chain, ...",TRUE
"5","7JW0","SARS-COV-2 SPIKE IN COMPLEX WITH THE S304 NEUTRALIZING ANTIBODY FAB FRAGMENT","ELECTRON MICROSCOPY (4.3 Å)","SARS-CoV-2 spike glycoprotein, S304 Fab light chain, S304 Fab heavy chain, ...",TRUE
"6","7K5I","SARS-COV-2 NSP1 IN COMPLEX WITH HUMAN 40S RIBOSOME","ELECTRON MICROSCOPY (2.9 Å)","40S ribosomal protein S17, 40S ribosomal rRNA18S, 40S ribosomal protein S29, ...",TRUE
"7","7JVA","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING DOMAIN AND FAB VARIABLE DOMAINS)","ELECTRON MICROSCOPY (3.6 Å)","S2A4 Fab heavy chain, S2A4 Fab light chain, SARS-CoV-2 spike glycoprotein, ...",TRUE
"8","6ZPE","NONSTRUCTURAL PROTEIN 10 (NSP10) FROM SARS COV-2","X-RAY DIFFRACTION (1.58 Å)","Replicase polyprotein 1ab, ZINC ION, GLYCEROL, ...",TRUE
"9","7JV6","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION)","ELECTRON MICROSCOPY (3 Å)","SARS-CoV-2 spike glycoprotein, S2H13 Fab heavy chain, S2H13 Fab light chain, ...",TRUE
"10","7JV2","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING MOTIF AND FAB VARIABLE DOMAINS)","ELECTRON MICROSCOPY (3.5 Å)","S2H13 Fab heavy chain, S2H13 Fab light chain, SARS-CoV-2 spike glycoprotein",TRUE
"11","7JV4","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (ONE RBD OPEN)","ELECTRON MICROSCOPY (3.4 Å)","SARS-CoV-2 spike glycoprotein, S2H13 Fab heavy chain, S2H13 Fab light chain, ...",FALSE
"12","7JVC","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT","ELECTRON MICROSCOPY (3.3 Å)","SARS-CoV-2 spike glycoprotein, S2A4 Fab heavy chain, S2A4 Fab light chain, ...",TRUE
"13","7KAG","CRYSTAL STRUCTURE OF THE UBIQUITIN-LIKE DOMAIN 1 (UBL1) OF NSP3 FROM SARS-COV-2","X-RAY DIFFRACTION (3.21 Å)","Non-structural protein 3, 1,2-ETHANEDIOL, SULFATE ION",TRUE
"14","7JWB","SARS COV2 SPIKE ECTODOMAIN WITH ENGINEERED TRIMERIZED VH BINDER","ELECTRON MICROSCOPY (6 Å)","autonomous human heavy chain variable domain, Spike glycoprotein",TRUE
"15","7K4N","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT","ELECTRON MICROSCOPY (3.3 Å)","Spike glycoprotein, S2E12 neutralizing antibody Fab fragment (heavy chain), S2E12 neutralizing antibody Fab fragment (light chain), ...",TRUE
"16","7JOX","ACYL-ENZYME INTERMEDIATE STRUCTURE OF SARS-COV-2 MPRO IN COMPLEX WITH ITS C-TERMINAL AUTOPROCESSING SEQUENCE.","X-RAY DIFFRACTION (1.95 Å)","3C-like proteinase, DIMETHYL SULFOXIDE",FALSE
"17","7D47","CRYSTAL STRUCTURE OF SARS-COV-2 PAPAIN-LIKE PROTEASE C111S","X-RAY DIFFRACTION (1.97 Å)","Non-structural protein 3, ZINC ION, CALCIUM ION",TRUE
"18","7JP1","STRUCTURE OF WILD-TYPE SUBSTRATE FREE SARS-COV-2 MPRO.","X-RAY DIFFRACTION (1.8 Å)","3C-like proteinase",FALSE
"19","7K43","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT","ELECTRON MICROSCOPY (2.6 Å)","SARS-CoV-2 spike glycoprotein, S2M11 Fab fragment (heavy chain), S2M11 Fab fragment (light chain), ...",TRUE
"20","7D3I","CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH MI-23","X-RAY DIFFRACTION (2.004 Å)","3C-like proteinase, (3~{S},3~{a}~{S},6~{a}~{R})-2-[3-[3,5-bis(fluoranyl)phenyl]propanoyl]-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrole-3-carboxamide, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL",FALSE
"21","7JOY","PRODUCT STRUCTURE OF SARS-COV-2 MPRO C145A MUTANT IN COMPLEX WITH ITS C-TERMINAL AUTOPROCESSING SEQUENCE.","X-RAY DIFFRACTION (2 Å)","3C-like proteinase",TRUE
"22","7K45","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND FAB VARIABLE DOMAINS)","ELECTRON MICROSCOPY (3.7 Å)","S2E12 neutralizing antibody Fab fragment (heavy chain), S2E12 neutralizing antibody Fab fragment (light chain), Spike glycoprotein, ...",TRUE
"23","5RL8","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z53825177","X-RAY DIFFRACTION (2.21 Å)","Helicase, N-(2-fluorophenyl)ethanesulfonamide, ZINC ION, ...",FALSE
"24","5RL6","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z198195770","X-RAY DIFFRACTION (1.921 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"25","7CWC","AMBIENT-TEMPERATURE SERIAL FEMTOSECOND X-RAY CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE AT 2.1 A RESOLUTION (P212121)","X-RAY DIFFRACTION (2.1 Å)","3C-like proteinase",TRUE
"26","6XCM","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1)","ELECTRON MICROSCOPY (3.42 Å)","Spike glycoprotein, C105 Fab Heavy Chain, C105 Fab Light Chain, ...",TRUE
"27","6XCN","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2)","ELECTRON MICROSCOPY (3.66 Å)","Spike glycoprotein, C105 Fab Heavy Chain, C105 Fab Light Chain, ...",FALSE
"28","6ZGG","FURIN CLEAVED SPIKE PROTEIN OF SARS-COV-2 WITH ONE RBD ERECT","ELECTRON MICROSCOPY (3.8 Å)","Spike glycoprotein",FALSE
"29","6ZGH","FURIN CLEAVED SPIKE PROTEIN OF SARS-COV-2 IN INTERMEDIATE CONFORMATION","ELECTRON MICROSCOPY (6.8 Å)","Receptor-type tyrosine-protein phosphatase S,Spike glycoprotein,Fibritin",FALSE
"30","6Z97","STRUCTURE OF THE PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN","ELECTRON MICROSCOPY (3.4 Å)","Spike glycoprotein,Fibritin, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"31","6ZGI","FURIN CLEAVED SPIKE PROTEIN OF SARS-COV-2 IN CLOSED CONFORMATION","ELECTRON MICROSCOPY (2.9 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"32","7C8V","STRUCTURE OF SYBODY SR4 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD)","X-RAY DIFFRACTION (2.15 Å)","Synthetic nanobody SR4, Spike glycoprotein, GLYCEROL, ...",TRUE
"33","6ZCT","NONSTRUCTURAL PROTEIN 10 (NSP10) FROM SARS COV-2","X-RAY DIFFRACTION (2.55 Å)","nsp10, ZINC ION",FALSE
"34","6ZER","CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB","X-RAY DIFFRACTION (3.8 Å)","RBD, heavy chain, light chain, ...",TRUE
"35","6ZCZ","CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN TERNARY COMPLEX WITH EY6A FAB AND A NANOBODY.","X-RAY DIFFRACTION (2.65 Å)","Spike glycoprotein, Nanobody, EY6A heavy chain, ...",TRUE
"36","7C8W","STRUCTURE OF SYBODY MR17 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD)","X-RAY DIFFRACTION (2.77 Å)","Synthetic nanobody MR17, Spike glycoprotein, alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"37","7CAN","STRUCTURE OF SYBODY MR17-K99Y IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD)","X-RAY DIFFRACTION (2.94 Å)","sybody MR17-K99Y, Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"38","7C8U","THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH GC376","X-RAY DIFFRACTION (2.35 Å)","Replicase polyprotein 1ab, (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",FALSE
"39","6XG3","THE CRYSTAL STRUCTURE OF PAPAIN-LIKE PROTEASE OF SARS COV-2 , C111S MUTANT, AT ROOM TEMPERATURE","X-RAY DIFFRACTION (2.48 Å)","Peptidase C16, ZINC ION, PHOSPHATE ION, ...",FALSE
"40","6XFN","CRYSTAL STRUCTURE OF THE SARS-COV-2 (COVID-19) MAIN PROTEASE IN COMPLEX WITH UAW243","X-RAY DIFFRACTION (1.7 Å)","main protease, UAW243, GLYCEROL",FALSE
"41","6XDG","COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS OF TWO NEUTRALIZING ANTIBODIES","ELECTRON MICROSCOPY (3.9 Å)","Spike glycoprotein, REGN10933 antibody Fab fragment light chain, REGN10933 antibody Fab fragment heavy chain, ...",TRUE
"42","6XB2","ROOM TEMPERATURE X-RAY CRYSTALLOGRAPHY REVEALS CATALYTIC CYSTEINE IN THE SARS-COV-2 3CL MPRO IS HIGHLY REACTIVE: INSIGHTS FOR ENZYME MECHANISM AND DRUG DESIGN","X-RAY DIFFRACTION (2.1 Å)","3C-like proteinase, 1-ETHYL-PYRROLIDINE-2,5-DIONE, DIMETHYL SULFOXIDE",FALSE
"43","7C8R","COMPLEX STRUCTURE OF SARS-COV-2 3CL PROTEASE WITH TG-0203770","X-RAY DIFFRACTION (2.3 Å)","3C-like proteinase, ethyl (4R)-4-[[(2S)-4-methyl-2-[[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-2-(phenylmethoxycarbonylamino)butanoyl]amino]pentanoyl]amino]-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pentanoate",FALSE
"44","6XA4","CRYSTAL STRUCTURE OF THE SARS-COV-2 (COVID-19) MAIN PROTEASE IN COMPLEX WITH UAW241","X-RAY DIFFRACTION (1.65 Å)","main protease, inhibitor UAW241, GLYCEROL",TRUE
"45","6XBH","CRYSTAL STRUCTURE OF THE SARS-COV-2 (COVID-19) MAIN PROTEASE IN COMPLEX WITH INHIBITOR UAW247","X-RAY DIFFRACTION (1.6 Å)","main protease, inhibitor UAW247, GLYCEROL, ...",TRUE
"46","6XCH","STRUCTURE OF THE COMPLEX BETWEEN THE SARS-COV-2 MAIN PROTEASE AND LEUPEPTIN","X-RAY DIFFRACTION (2.2 Å)","3C-like proteinase, Leupeptin",FALSE
"47","6XDC","CRYO-EM STRUCTURE OF SARS-COV-2 ORF3A","ELECTRON MICROSCOPY (2.9 Å)","Protein 3a",TRUE
"48","6XB1","ROOM TEMPERATURE X-RAY CRYSTALLOGRAPHY REVEALS CATALYTIC CYSTEINE IN THE SARS-COV-2 3CL MPRO IS HIGHLY REACTIVE: INSIGHTS FOR ENZYME MECHANISM AND DRUG DESIGN","X-RAY DIFFRACTION (1.8 Å)","3C-like proteinase, 1-ETHYL-PYRROLIDINE-2,5-DIONE",FALSE
"49","6XAA","SARS COV-2 PLPRO IN COMPLEX WITH UBIQUITIN PROPARGYLAMIDE","X-RAY DIFFRACTION (2.7 Å)","Papain-like protease, Ubiquitin-propargylamide, ZINC ION",TRUE
"50","6M5I","CRYSTAL STRUCTURE OF 2019-NCOV NSP7-NSP8C COMPLEX","X-RAY DIFFRACTION (2.496 Å)","SARS-CoV-2 nsp8, SARS-CoV-2 nsp7",TRUE
"51","6XB0","ROOM TEMPERATURE X-RAY CRYSTALLOGRAPHY REVEALS CATALYTIC CYSTEINE IN THE SARS-COV-2 3CL MPRO IS HIGHLY REACTIVE: INSIGHTS FOR ENZYME MECHANISM AND DRUG DESIGN","X-RAY DIFFRACTION (1.8 Å)","3C-like proteinase, DIMETHYL SULFOXIDE",FALSE
"52","6XBG","CRYSTAL STRUCTURE OF THE SARS-COV-2 (COVID-19) MAIN PROTEASE IN COMPLEX WITH INHIBITOR UAW246","X-RAY DIFFRACTION (1.45 Å)","main protease, inhibitor UAW246, GLYCEROL, ...",TRUE
"53","6XA9","SARS COV-2 PLPRO IN COMPLEX WITH ISG15 C-TERMINAL DOMAIN PROPARGYLAMIDE","X-RAY DIFFRACTION (2.9 Å)","Papain-like protease, ISG15 CTD-propargylamide, GLYCEROL, ...",TRUE
"54","6Z4U","X-RAY CRYSTALLOGRAPHIC STRUCTURE OF ORF9B FROM SARS-COV-2","X-RAY DIFFRACTION (1.95 Å)","Protein 9b, POLYETHYLENE GLYCOL (N=34)",TRUE
"55","6XDH","CRYSTAL STRUCTURE OF NENDOU (URIDYLATE-SPECIFIC ENDORIBONUCLEASE, NSP15) FROM BETACORONAVIRUS SARS-COV-2","X-RAY DIFFRACTION (2.35 Å)","Uridylate-specific endoribonuclease, ACETATE ION, CITRIC ACID, ...",TRUE
"56","6Z2E","CRYSTAL STRUCTURE OF SARS-COV-2 MPRO IN COMPLEX WITH THE ACTIVITY-BASED PROBE, BIOTIN-PEG(4)-ABU-TLE-LEU-GLN-VINYLSULFONE","X-RAY DIFFRACTION (1.7 Å)","Main Protease, (4~{S})-4-[[(2~{S})-2-[[(2~{S})-2-[[(2~{S})-2-[3-[2-[2-[2-[2-[5-[(3~{a}~{S},4~{R},6~{a}~{R})-2-oxidanylidene-3,3~{a},4,6~{a}-tetrahydro-1~{H}-thieno[3,4-d]imidazol-4-yl]pentanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]butanoyl]amino]-3,3-dimethyl-butanoyl]amino]-4-methyl-pentanoyl]amino]-6-methylsulfonyl-hexanamide, CHLORIDE ION, ...",FALSE
"57","7BQ7","CRYSTAL STRUCTURE OF 2019-NCOV NSP16-NSP10 COMPLEX","X-RAY DIFFRACTION (2.37 Å)","SARS-CoV-2 nsp16, SARS-CoV-2 nsp10, S-ADENOSYLMETHIONINE, ...",TRUE
"58","6XBI","CRYSTAL STRUCTURE OF THE SARS-COV-2 (COVID-19) MAIN PROTEASE IN COMPLEX WITH INHIBITOR UAW248","X-RAY DIFFRACTION (1.7 Å)","main protease, inhibitor UAW248, GLYCEROL, ...",TRUE
"59","7C8T","COMPLEX STRUCTURE OF SARS-COV-2 3CL PROTEASE WITH TG-0205221","X-RAY DIFFRACTION (2.05 Å)","3C-like proteinase, N-[(BENZYLOXY)CARBONYL]-O-(TERT-BUTYL)-L-THREONYL-3-CYCLOHEXYL-N-[(1S)-2-HYDROXY-1-{[(3S)-2-OXOPYRROLIDIN-3-YL]METHYL}ETHYL]-L-ALANINAMIDE",FALSE
"60","5RHE","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PG-COV-42 (MPRO-X2052)","X-RAY DIFFRACTION (1.56 Å)","3C-like proteinase, 1-acetyl-N-(6-methoxypyridin-3-yl)piperidine-4-carboxamide, DIMETHYL SULFOXIDE",FALSE
"61","5RHD","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH SF013 (MPRO-X2193)","X-RAY DIFFRACTION (1.57 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[4-(methylsulfonyl)phenyl]piperazine",FALSE
"62","6X6P","CHARACTERIZATION OF THE SARS-COV-2 S PROTEIN: BIOPHYSICAL, BIOCHEMICAL, STRUCTURAL, AND ANTIGENIC ANALYSIS","ELECTRON MICROSCOPY (3.22 Å)","SARS-CoV-2 spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"63","5RHF","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PG-COV-34 (MPRO-X2754)","X-RAY DIFFRACTION (1.76 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-acetyl-N-methyl-N-phenylpiperidine-4-carboxamide",FALSE
"64","5RHC","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH COV_HETLIB053 (MPRO-X2119)","X-RAY DIFFRACTION (1.58 Å)","3C-like proteinase, (E)-1-(1H-imidazol-2-yl)methanimine, DIMETHYL SULFOXIDE",FALSE
"65","5RHB","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH COV_HETLIB030 (MPRO-X2097)","X-RAY DIFFRACTION (1.43 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, (E)-1-(pyrimidin-2-yl)methanimine",FALSE
"66","7BYR","BD23-FAB IN COMPLEX WITH THE S ECTODOMAIN TRIMER","ELECTRON MICROSCOPY (3.84 Å)","SARS-CoV-2 Spike glycoprotein, Ab23-Fab-Heavy Chain, Ab23-Fab-Light Chain, ...",TRUE
"67","6YZ7","H11-D4, SARS-COV-2 RBD, CR3022 TERNARY COMPLEX","X-RAY DIFFRACTION (3.3 Å)","Spike glycoprotein, Antibody Cr3022, Antibody light chain, ...",TRUE
"68","6YZ5","H11-D4 COMPLEX WITH SARS-COV-2 RBD","X-RAY DIFFRACTION (1.8 Å)","Spike glycoprotein, Nanobody H11-D4, 2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"69","7BZF","COVID-19 RNA-DEPENDENT RNA POLYMERASE POST-TRANSLOCATED CATALYTIC COMPLEX","ELECTRON MICROSCOPY (3.26 Å)","RNA-directed RNA polymerase, Non-structural protein 8, Non-structural protein 7, ...",TRUE
"70","6Z43","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-D4 NANOBODY COMPLEX","ELECTRON MICROSCOPY (3.3 Å)","Spike glycoprotein, Nanobody, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"71","6Z2M","H11-D4, SARS-COV-2 RBD, CR3022 TERNARY COMPLEX","X-RAY DIFFRACTION (2.71 Å)","Spike glycoprotein, CR3022 antibody, nanobody D4, ...",TRUE
"72","7C2K","COVID-19 RNA-DEPENDENT RNA POLYMERASE PRE-TRANSLOCATED CATALYTIC COMPLEX","ELECTRON MICROSCOPY (2.93 Å)","RNA-directed RNA polymerase, Non-structural protein 8, Non-structural protein 7, ...",TRUE
"73","6M1V","CRYSTAL STRUCTURE OF POST FUSION CORE OF 2019-NCOV S2 SUBUNIT","X-RAY DIFFRACTION (1.5 Å)","spike protein",TRUE
"74","6X4I","CRYSTAL STRUCTURE OF NSP15 ENDORIBONUCLEASE FROM SARS COV-2 IN THE COMPLEX WITH 3'-URIDINEMONOPHOSPHATE","X-RAY DIFFRACTION (1.85 Å)","Uridylate-specific endoribonuclease, 3'-URIDINEMONOPHOSPHATE, 1,2-ETHANEDIOL, ...",FALSE
"75","7BWJ","CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY WITH RBD","X-RAY DIFFRACTION (2.85 Å)","SARS-CoV-2 receptor binding domain, antibody light chain, antibody heavy chain, ...",TRUE
"76","6WPT","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT (OPEN STATE)","ELECTRON MICROSCOPY (3.7 Å)","SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain, ...",FALSE
"77","7BW4","STRUCTURE OF THE RNA-DEPENDENT RNA POLYMERASE FROM SARS-COV-2","ELECTRON MICROSCOPY (3.7 Å)","Replicase polyprotein 1ab, ZINC ION",TRUE
"78","5RH9","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z4438424255 (MPRO-X2776)","X-RAY DIFFRACTION (1.91 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-{4-[(1S)-1-methoxyethyl]phenyl}-N-[(1R)-2-[(4-methoxy-2-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide",FALSE
"79","5RH3","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1264525706 (MPRO-X2649)","X-RAY DIFFRACTION (1.69 Å)","3C-like proteinase, (2R)-2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide, DIMETHYL SULFOXIDE",FALSE
"80","6WZO","STRUCTURE OF SARS-COV-2 NUCLEOCAPSID DIMERIZATION DOMAIN, P1 FORM","X-RAY DIFFRACTION (1.42 Å)","Nucleoprotein",TRUE
"81","6X2B","SARS-COV-2 U1S2Q 2 RBD UP SPIKE PROTEIN TRIMER","ELECTRON MICROSCOPY (3.6 Å)","Spike glycoprotein",FALSE
"82","6X2C","SARS-COV-2 U1S2Q ALL DOWN RBD STATE SPIKE PROTEIN TRIMER","ELECTRON MICROSCOPY (3.2 Å)","Spike glycoprotein",TRUE
"83","5RGV","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z4444622066 (MPRO-X2563)","X-RAY DIFFRACTION (1.82 Å)","3C-like proteinase, 2-(isoquinolin-4-yl)-N-phenylacetamide, DIMETHYL SULFOXIDE",FALSE
"84","5RH8","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z4444621965 (MPRO-X2764)","X-RAY DIFFRACTION (1.81 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 2-(cyanomethoxy)-N-[(1,2-thiazol-4-yl)methyl]benzamide",FALSE
"85","5RH7","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z4439011584 (MPRO-X2705)","X-RAY DIFFRACTION (1.71 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-(5-tert-butyl-1H-pyrazol-3-yl)-N-[(1R)-2-[(2-ethyl-6-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide",FALSE
"86","5RGZ","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1343543528 (MPRO-X2600)","X-RAY DIFFRACTION (1.52 Å)","3C-like proteinase, 2-(3-cyanophenyl)-N-(pyridin-3-yl)acetamide, DIMETHYL SULFOXIDE",FALSE
"87","7C2I","CRYSTAL STRUCTURE OF NSP16-NSP10 HETERODIMER FROM SARS-COV-2 IN COMPLEX WITH SAM (WITH ADDITIONAL SAM DURING CRYSTALLIZATION)","X-RAY DIFFRACTION (2.5 Å)","Replicase polyprotein 1ab, S-ADENOSYLMETHIONINE, ZINC ION",TRUE
"88","7C01","MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD","X-RAY DIFFRACTION (2.88 Å)","SARS-Cov-2 Spike protein S1, CB6 heavy chain, CB6 light chain, ...",TRUE
"89","6X1B","CRYSTAL STRUCTURE OF NSP15 ENDORIBONUCLEASE FROM SARS COV-2 IN THE COMPLEX WITH THE PRODUCT NUCLEOTIDE GPU.","X-RAY DIFFRACTION (1.97 Å)","Uridylate-specific endoribonuclease, DNA (5'-R(*GP*U)-3'), PHOSPHATE ION, ...",TRUE
"90","5RH6","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z4439011588 (MPRO-X2703)","X-RAY DIFFRACTION (1.6 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(1R)-2-[(2-ethyl-6-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]-N-[6-(propan-2-yl)pyridin-3-yl]propanamide",FALSE
"91","6X2A","SARS-COV-2 U1S2Q 1 UP RBD SPIKE PROTEIN TRIMER","ELECTRON MICROSCOPY (3.3 Å)","Spike glycoprotein",TRUE
"92","7C2J","CRYSTAL STRUCTURE OF NSP16-NSP10 HETERODIMER FROM SARS-COV-2 IN COMPLEX WITH SAM (WITHOUT ADDITIONAL SAM DURING CRYSTALLIZATION)","X-RAY DIFFRACTION (2.799 Å)","Replicase polyprotein 1ab, S-ADENOSYLMETHIONINE, ZINC ION",FALSE
"93","6X29","SARS-COV-2 RS2D DOWN STATE SPIKE PROTEIN TRIMER","ELECTRON MICROSCOPY (2.7 Å)","Spike glycoprotein",TRUE
"94","6WZQ","STRUCTURE OF SARS-COV-2 NUCLEOCAPSID DIMERIZATION DOMAIN, P21 FORM","X-RAY DIFFRACTION (1.45 Å)","Nucleoprotein, SULFATE ION",TRUE
"95","5RH1","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z2010253653 (MPRO-X2643)","X-RAY DIFFRACTION (1.96 Å)","3C-like proteinase, 2-(5-chlorothiophen-2-yl)-N-(pyridin-3-yl)acetamide, DIMETHYL SULFOXIDE",FALSE
"96","5RGX","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1344037997 (MPRO-X2572)","X-RAY DIFFRACTION (1.69 Å)","3C-like proteinase, 2-(3-cyanophenyl)-N-(4-methylpyridin-3-yl)acetamide, DIMETHYL SULFOXIDE",FALSE
"97","6WZU","THE CRYSTAL STRUCTURE OF PAPAIN-LIKE PROTEASE OF SARS COV-2 , P3221 SPACE GROUP","X-RAY DIFFRACTION (1.79 Å)","Non-structural protein 3, ZINC ION, GLYCEROL, ...",TRUE
"98","5RH0","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1286870272 (MPRO-X2608)","X-RAY DIFFRACTION (1.916 Å)","3C-like proteinase, N-(5-methylthiophen-2-yl)-N'-pyridin-3-ylurea, DIMETHYL SULFOXIDE",FALSE
"99","5RHA","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z147647874 (MPRO-X2779)","X-RAY DIFFRACTION (1.51 Å)","3C-like proteinase, 1-{4-[(thiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one, DIMETHYL SULFOXIDE",FALSE
"100","5RGW","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z4444621910 (MPRO-X2569)","X-RAY DIFFRACTION (1.43 Å)","3C-like proteinase, 2-(5-cyanopyridin-3-yl)-N-(pyridin-3-yl)acetamide, DIMETHYL SULFOXIDE",FALSE
"101","5RH4","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1530425063 (MPRO-X2659)","X-RAY DIFFRACTION (1.34 Å)","3C-like proteinase, (2R)-2-(6-chloro-9H-carbazol-2-yl)propanoic acid, DIMETHYL SULFOXIDE",FALSE
"102","5RGT","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z4439011607 (MPRO-X2540)","X-RAY DIFFRACTION (2.22 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(1R)-2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)propanamide",FALSE
"103","5RGU","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z4444622180 (MPRO-X2562)","X-RAY DIFFRACTION (2.108 Å)","3C-like proteinase, N-(3-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-2-(pyrimidin-5-yl)acetamide, DIMETHYL SULFOXIDE",FALSE
"104","5RH2","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1129289650 (MPRO-X2646)","X-RAY DIFFRACTION (1.827 Å)","3C-like proteinase, 2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)acetamide, DIMETHYL SULFOXIDE",FALSE
"105","5RGY","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1535580916 (MPRO-X2581)","X-RAY DIFFRACTION (1.976 Å)","3C-like proteinase, N-(4-methoxypyridin-2-yl)-2-(naphthalen-2-yl)acetamide, DIMETHYL SULFOXIDE",FALSE
"106","5RH5","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z4439011520 (MPRO-X2694)","X-RAY DIFFRACTION (1.72 Å)","3C-like proteinase, N-(5-tert-butyl-1,2-oxazol-3-yl)-N-[(1R)-2-[(4-methoxy-2-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide, DIMETHYL SULFOXIDE",FALSE
"107","6WPS","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT","ELECTRON MICROSCOPY (3.1 Å)","SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain, ...",TRUE
"108","6YVF","STRUCTURE OF SARS-COV-2 MAIN PROTEASE BOUND TO AZD6482.","X-RAY DIFFRACTION (1.6 Å)","Replicase polyprotein 1ab, 2-[[(1R)-1-(7-methyl-2-morpholin-4-yl-4-oxidanylidene-pyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoic acid, CHLORIDE ION, ...",FALSE
"109","6WTK","FELINE CORONAVIRUS DRUG INHIBITS THE MAIN PROTEASE OF SARS-COV-2 AND BLOCKS VIRUS REPLICATION","X-RAY DIFFRACTION (2 Å)","3C-like proteinase, N~2~-[(benzyloxy)carbonyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide",FALSE
"110","6WUU","CRYSTAL STRUCTURE OF THE SARS COV-2 PAPAIN-LIKE PROTEASE IN COMPLEX WITH PEPTIDE INHIBITOR VIR250","X-RAY DIFFRACTION (2.79 Å)","papain-like protease, VIR250, ZINC ION, ...",TRUE
"111","6WTT","CRYSTALS STRUCTURE OF THE SARS-COV-2 (COVID-19) MAIN PROTEASE WITH INHIBITOR GC-376","X-RAY DIFFRACTION (2.15 Å)","3C-like proteinase, (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid, DI(HYDROXYETHYL)ETHER, ...",TRUE
"112","6WXD","SARS-COV-2 NSP9 RNA-REPLICASE","X-RAY DIFFRACTION (2 Å)","Non-structural protein 9, SULFATE ION",TRUE
"113","6WTM","FELINE CORONAVIRUS DRUG INHIBITS THE MAIN PROTEASE OF SARS-COV-2 AND BLOCKS VIRUS REPLICATION","X-RAY DIFFRACTION (1.85 Å)","3C-like proteinase",FALSE
"114","6YUN","1.45 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF C-TERMINAL DIMERIZATION DOMAIN OF NUCLEOCAPSID PHOSPHOPROTEIN FROM SARS-COV-2","X-RAY DIFFRACTION (1.44 Å)","Nucleoprotein",FALSE
"115","6YZ6","STRUCTURE OF THE HEMIACETAL COMPLEX BETWEEN THE SARS-COV-2 MAIN PROTEASE AND LEUPEPTIN","X-RAY DIFFRACTION (1.7 Å)","Main Protease, LEUPEPTIN, DIMETHYL SULFOXIDE, ...",TRUE
"116","7C22","CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF SARS-COV-2 NUCLEOCAPSID PROTEIN","X-RAY DIFFRACTION (2 Å)","Nucleoprotein, ACETATE ION, DI(HYDROXYETHYL)ETHER",TRUE
"117","6WTJ","FELINE CORONAVIRUS DRUG INHIBITS THE MAIN PROTEASE OF SARS-COV-2 AND BLOCKS VIRUS REPLICATION","X-RAY DIFFRACTION (1.9 Å)","3C-like proteinase, (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",FALSE
"118","6WXC","CRYSTAL STRUCTURE OF NSP15 ENDORIBONUCLEASE FROM SARS COV-2 IN THE COMPLEX WITH POTENTIAL REPURPOSING DRUG TIPIRACIL","X-RAY DIFFRACTION (1.85 Å)","Uridylate-specific endoribonuclease, 5-CHLORO-6-(1-(2-IMINOPYRROLIDINYL) METHYL) URACIL, PHOSPHATE ION, ...",FALSE
"119","6WX4","CRYSTAL STRUCTURE OF THE SARS COV-2 PAPAIN-LIKE PROTEASE IN COMPLEX WITH PEPTIDE INHIBITOR VIR251","X-RAY DIFFRACTION (1.655 Å)","Non-structural protein 3, VIR251, ZINC ION",TRUE
"120","6WVN","CRYSTAL STRUCTURE OF NSP16-NSP10 FROM SARS-COV-2 IN COMPLEX WITH 7-METHYL-GPPPA AND S-ADENOSYLMETHIONINE.","X-RAY DIFFRACTION (2 Å)","2'-O-methyltransferase, Non-structural protein 10, CHLORIDE ION, ...",FALSE
"121","6YVA","PLPRO-C111S WITH MISG15","X-RAY DIFFRACTION (3.18 Å)","Replicase polyprotein 1a, Ubiquitin-like protein ISG15, ZINC ION",TRUE
"122","7BRR","CRYSTAL STRUCTURE OF THE 2019-NCOV MAIN PROTEASE COMPLEXED WITH GC376","X-RAY DIFFRACTION (1.4 Å)","3C-like proteinase, (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",FALSE
"123","7BRO","CRYSTAL STRUCTURE OF THE 2019-NCOV MAIN PROTEASE","X-RAY DIFFRACTION (2 Å)","3C-like proteinase",FALSE
"124","7BRP","CRYSTAL STRUCTURE OF THE 2019-NCOV MAIN PROTEASE COMPLEXED WITH BOCEPREVIR","X-RAY DIFFRACTION (1.8 Å)","3C-like proteinase, (1R,2S,5S)-N-[(1S)-3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL]-3-[(2S)-2-{[(TERT-BUTYLAMINO)CARBONYL]AMINO}-3,3-DIMETHYLBUTANOYL]-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE",FALSE
"125","7BZ5","STRUCTURE OF COVID-19 VIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH A NEUTRALIZING ANTIBODY","X-RAY DIFFRACTION (1.84 Å)","Spike protein S1, Heavy chain of B38, Light chain of B38, ...",TRUE
"126","6WTC","CRYSTAL STRUCTURE OF THE SECOND FORM OF THE CO-FACTOR COMPLEX OF NSP7 AND THE C-TERMINAL DOMAIN OF NSP8 FROM SARS COV-2","X-RAY DIFFRACTION (1.85 Å)","SARS-CoV-2 NSP7, SARS-CoV-2 NSP8, ACETIC ACID",FALSE
"127","6YZ1","THE CRYSTAL STRUCTURE OF SARS-COV-2 NSP10-NSP16 METHYLTRANSFERASE COMPLEX WITH SINEFUNGIN","X-RAY DIFFRACTION (2.4 Å)","nsp16, nsp10, SINEFUNGIN, ...",TRUE
"128","6YYT","STRUCTURE OF REPLICATING SARS-COV-2 POLYMERASE","ELECTRON MICROSCOPY (2.9 Å)","nsp12, nsp8, nsp7, ...",TRUE
"129","6WRZ","CRYSTAL STRUCTURE OF NSP16-NSP10 HETERODIMER FROM SARS-COV-2 WITH 7-METHYL-GPPPA AND S-ADENOSYL-L-HOMOCYSTEINE IN THE ACTIVE SITE AND SULFATES IN THE MRNA BINDING GROOVE.","X-RAY DIFFRACTION (2.25 Å)","2'-O-methyltransferase, Non-structural protein 10, S-ADENOSYL-L-HOMOCYSTEINE, ...",FALSE
"130","6YWM","CRYSTAL STRUCTURE OF SARS-COV-2 (COVID-19) NSP3 MACRODOMAIN IN COMPLEX WITH MES","X-RAY DIFFRACTION (2.16 Å)","NSP3 macrodomain, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, 1,2-ETHANEDIOL, ...",TRUE
"131","6YT8","STRUCTURE OF SARS-COV-2 MAIN PROTEASE BOUND TO PYRITHIONE ZINC","X-RAY DIFFRACTION (2.05 Å)","Replicase polyprotein 1ab, 9-oxa-7-thia-1-azonia-8$l^{2}-zincabicyclo[4.3.0]nona-1,3,5-triene, IMIDAZOLE, ...",FALSE
"132","6WQD","THE 1.95 A CRYSTAL STRUCTURE OF THE CO-FACTOR COMPLEX OF NSP7 AND THE C-TERMINAL DOMAIN OF NSP8 FROM SARS-COV-2","X-RAY DIFFRACTION (1.95 Å)","SARS-CoV-2 NSP7, SARS-CoV-2 NSP8, 1,2-ETHANEDIOL",FALSE
"133","6WQ3","CRYSTAL STRUCTURE OF NSP16-NSP10 HETERODIMER FROM SARS-COV-2 IN COMPLEX WITH 7-METHYL-GPPPA AND S-ADENOSYL-L-HOMOCYSTEINE.","X-RAY DIFFRACTION (2.1 Å)","2'-O-methyltransferase, Non-structural protein 10, S-ADENOSYL-L-HOMOCYSTEINE, ...",FALSE
"134","6WOJ","STRUCTURE OF THE SARS-COV-2 MACRODOMAIN (NSP3) IN COMPLEX WITH ADP-RIBOSE","X-RAY DIFFRACTION (2.2 Å)","Non-structural protein 3, ADENOSINE-5-DIPHOSPHORIBOSE",TRUE
"135","6WQF","STRUCTURAL PLASTICITY OF THE SARS-COV-2 3CL MPRO ACTIVE SITE CAVITY REVEALED BY ROOM TEMPERATURE X-RAY CRYSTALLOGRAPHY","X-RAY DIFFRACTION (2.3 Å)","3C-like proteinase",FALSE
"136","6YWK","CRYSTAL STRUCTURE OF SARS-COV-2 (COVID-19) NSP3 MACRODOMAIN IN COMPLEX WITH HEPES","X-RAY DIFFRACTION (2.2 Å)","NSP3 macrodomain, 1,2-ETHANEDIOL, MAGNESIUM ION, ...",FALSE
"137","6WKS","STRUCTURE OF SARS-COV-2 NSP16/NSP10 IN COMPLEX WITH RNA CAP ANALOGUE (M7GPPPA) AND S-ADENOSYLMETHIONINE","X-RAY DIFFRACTION (1.8 Å)","2'-O-methyltransferase, Non-structural protein 10, S-ADENOSYLMETHIONINE, ...",TRUE
"138","6WRH","THE CRYSTAL STRUCTURE OF PAPAIN-LIKE PROTEASE OF SARS COV-2 , C111S MUTANT","X-RAY DIFFRACTION (1.6 Å)","Non-structural protein 3, ZINC ION, PHOSPHATE ION, ...",TRUE
"139","6WNP","X-RAY STRUCTURE OF SARS-COV-2 MAIN PROTEASE BOUND TO BOCEPREVIR AT 1.45 A","X-RAY DIFFRACTION (1.443 Å)","3C-like proteinase, boceprevir (bound form)",FALSE
"140","6YWL","CRYSTAL STRUCTURE OF SARS-COV-2 (COVID-19) NSP3 MACRODOMAIN IN COMPLEX WITH ADP-RIBOSE","X-RAY DIFFRACTION (2.5 Å)","NSP3 macrodomain, ADENOSINE-5-DIPHOSPHORIBOSE, 1,2-ETHANEDIOL, ...",FALSE
"141","6WEY","HIGH-RESOLUTION STRUCTURE OF THE SARS-COV-2 NSP3 MACRO X DOMAIN","X-RAY DIFFRACTION (0.95 Å)","Non-structural protein 3",TRUE
"142","7BUY","THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH CARMOFUR","X-RAY DIFFRACTION (1.6 Å)","SARS-CoV-2 virus Main protease, hexylcarbamic acid, DIMETHYL SULFOXIDE",FALSE
"143","6M0K","THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR 11B","X-RAY DIFFRACTION (1.504 Å)","Replicase polyprotein 1ab, DIMETHYL SULFOXIDE, ~{N}-[(2~{S})-3-(3-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide",TRUE
"144","6LZE","THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR 11A","X-RAY DIFFRACTION (1.505 Å)","Replicase polyprotein 1ab, DIMETHYL SULFOXIDE, ~{N}-[(2~{S})-3-cyclohexyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide",TRUE
"145","6YOR","STRUCTURE OF THE SARS-COV-2 SPIKE S1 PROTEIN IN COMPLEX WITH CR3022 FAB","ELECTRON MICROSCOPY (3.3 Å)","Spike glycoprotein, IgG H chain, IgG L chain",TRUE
"146","6YHU","CRYSTAL STRUCTURE OF THE NSP7-NSP8 COMPLEX OF SARS-COV-2","X-RAY DIFFRACTION (2 Å)","Replicase polyprotein 1a",TRUE
"147","6W37","STRUCTURE OF THE SARS-COV-2 ORF7A ENCODED ACCESSORY PROTEIN","X-RAY DIFFRACTION (2.9 Å)","Protein 7a",TRUE
"148","6YNQ","STRUCTURE OF SARS-COV-2 MAIN PROTEASE BOUND TO 2-METHYL-1-TETRALONE.","X-RAY DIFFRACTION (1.8 Å)","Replicase polyprotein 1ab, (2~{S})-2-methyl-3,4-dihydro-2~{H}-naphthalen-1-one, DIMETHYL SULFOXIDE, ...",FALSE
"149","6WKQ","1.98 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF NSP16-NSP10 HETERODIMER FROM SARS-COV-2 IN COMPLEX WITH SINEFUNGIN","X-RAY DIFFRACTION (1.98 Å)","SARS-CoV-2 NSP16, SARS-CoV-2 NSP10, SODIUM ION, ...",FALSE
"150","6WKP","CRYSTAL STRUCTURE OF RNA-BINDING DOMAIN OF NUCLEOCAPSID PHOSPHOPROTEIN FROM SARS COV-2, MONOCLINIC CRYSTAL FORM","X-RAY DIFFRACTION (2.67 Å)","SARS-CoV-2 nucleocapsid protein, ZINC ION, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID",TRUE
"151","6WLC","CRYSTAL STRUCTURE OF NSP15 ENDORIBONUCLEASE FROM SARS COV-2 IN THE COMPLEX WITH URIDINE-5'-MONOPHOSPHATE","X-RAY DIFFRACTION (1.82 Å)","Uridylate-specific endoribonuclease, URIDINE-5'-MONOPHOSPHATE, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, ...",TRUE
"152","6YM0","CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH CR3022 FAB (CRYSTAL FORM 1)","X-RAY DIFFRACTION (4.36 Å)","Spike glycoprotein, heavy chain, light chain",TRUE
"153","6WJI","2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF C-TERMINAL DIMERIZATION DOMAIN OF NUCLEOCAPSID PHOSPHOPROTEIN FROM SARS-COV-2","X-RAY DIFFRACTION (2.052 Å)","SARS-CoV-2 nucleocapsid protein, CHLORIDE ION",FALSE
"154","7BV1","CRYO-EM STRUCTURE OF THE APO NSP12-NSP7-NSP8 COMPLEX","ELECTRON MICROSCOPY (2.8 Å)","nsp12, nsp8, nsp7, ...",TRUE
"155","6WJT","2.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF NSP16-NSP10 HETERODIMER FROM SARS-COV-2 IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEINE","X-RAY DIFFRACTION (2 Å)","2'-O-methyltransferase, Non-structural protein 10, SODIUM ION, ...",FALSE
"156","7BQY","THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR N3 AT 1.7 ANGSTROM","X-RAY DIFFRACTION (1.7 Å)","main protease, N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE",TRUE
"157","6WIQ","CRYSTAL STRUCTURE OF THE CO-FACTOR COMPLEX OF NSP7 AND THE C-TERMINAL DOMAIN OF NSP8 FROM SARS COV-2","X-RAY DIFFRACTION (2.85 Å)","SARS-CoV-2 NSP7, SARS-CoV-2 NSP8",FALSE
"158","7BV2","THE NSP12-NSP7-NSP8 COMPLEX BOUND TO THE TEMPLATE-PRIMER RNA AND TRIPHOSPHATE FORM OF REMDESIVIR(RTP)","ELECTRON MICROSCOPY (2.5 Å)","nsp12, nsp8, nsp7, ...",TRUE
"159","5RGP","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102628 (MPRO-X0771)","X-RAY DIFFRACTION (2.07 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(2,4-dimethylphenyl)sulfonyl]piperazin-1-yl}ethan-1-one",FALSE
"160","5RGM","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102142 (MPRO-X0708)","X-RAY DIFFRACTION (2.04 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N'-acetyl-4,5,6,7-tetrahydro-1-benzothiophene-2-carbohydrazide",FALSE
"161","6M2Q","SARS-COV-2 3CL PROTEASE (3CL PRO) APO STRUCTURE (SPACE GROUP C21)","X-RAY DIFFRACTION (1.7 Å)","SARS-CoV-2 3CL protease",FALSE
"162","5RGL","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102962 (MPRO-X0705)","X-RAY DIFFRACTION (1.76 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[4-(4-methylbenzene-1-carbonyl)piperazin-1-yl]ethan-1-one",FALSE
"163","5RG1","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH NCL-00024905","X-RAY DIFFRACTION (1.65 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, Nalpha-acetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide",FALSE
"164","6WEN","CRYSTAL STRUCTURE OF ADP RIBOSE PHOSPHATASE OF NSP3 FROM SARS-COV-2 IN THE APO FORM","X-RAY DIFFRACTION (1.35 Å)","Non-structural protein 3, CHLORIDE ION",FALSE
"165","5RGK","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1310876699 (MPRO-X0426)","X-RAY DIFFRACTION (1.43 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide",FALSE
"166","5RGR","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z328695024 (MPRO-X1101)","X-RAY DIFFRACTION (1.41 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N,1-dimethyl-N-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",FALSE
"167","5RGS","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1259086950 (MPRO-X1163)","X-RAY DIFFRACTION (1.72 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, [(2~{R})-4-(phenylmethyl)morpholin-2-yl]methanol",FALSE
"168","6M2N","SARS-COV-2 3CL PROTEASE (3CL PRO) IN COMPLEX WITH A NOVEL INHIBITOR","X-RAY DIFFRACTION (2.198 Å)","SARS-CoV-2 3CL protease, 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one",FALSE
"169","5RG3","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH NCL-00025412","X-RAY DIFFRACTION (1.58 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N~2~-acetyl-N~1~-prop-2-en-1-yl-L-aspartamide",FALSE
"170","5RGG","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z2856434890 (MPRO-X0165)","X-RAY DIFFRACTION (2.26 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 4-methyl-N-phenylpiperazine-1-carboxamide",FALSE
"171","5RGQ","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1849009686 (MPRO-X1086)","X-RAY DIFFRACTION (2.15 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-(4-fluoro-2-methylphenyl)methanesulfonamide",FALSE
"172","6YLA","CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH CR3022 FAB","X-RAY DIFFRACTION (2.42 Å)","Spike glycoprotein, Heavy Chain, Light chain, ...",TRUE
"173","5RGI","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z369936976 (MPRO-X0397)","X-RAY DIFFRACTION (1.57 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea",FALSE
"174","5RGH","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1619978933 (MPRO-X0395)","X-RAY DIFFRACTION (1.7 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 5-fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine",FALSE
"175","5RGJ","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1401276297 (MPRO-X0425)","X-RAY DIFFRACTION (1.34 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, (5S)-7-(pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane",FALSE
"176","6WCF","CRYSTAL STRUCTURE OF ADP RIBOSE PHOSPHATASE OF NSP3 FROM SARS-COV-2 IN COMPLEX WITH MES","X-RAY DIFFRACTION (1.065 Å)","Non-structural protein 3, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID",TRUE
"177","5RGO","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102248 (MPRO-X0736)","X-RAY DIFFRACTION (1.74 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[4-(furan-2-carbonyl)piperazin-1-yl]ethan-1-one",FALSE
"178","5RGN","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102759 (MPRO-X0731)","X-RAY DIFFRACTION (1.86 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(4-methylphenyl)sulfonyl]piperazin-1-yl}ethan-1-one",FALSE
"179","5RG2","PANDDA ANALYSIS GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE FRAGMENT SCREEN -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH NCL-00025058","X-RAY DIFFRACTION (1.63 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N~2~-acetyl-N-prop-2-en-1-yl-D-allothreoninamide",FALSE
"180","6YI3","THE N-TERMINAL RNA-BINDING DOMAIN OF THE SARS-COV-2 NUCLEOCAPSID PHOSPHOPROTEIN","SOLUTION NMR","Nucleoprotein",TRUE
"181","6W9Q","PEPTIDE-BOUND SARS-COV-2 NSP9 RNA-REPLICASE","X-RAY DIFFRACTION (2.05 Å)","3C-like proteinase peptide, Non-structural protein 9 fusion, PHOSPHATE ION",TRUE
"182","7BTF","SARS-COV-2 RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH COFACTORS IN REDUCED CONDITION","ELECTRON MICROSCOPY (2.95 Å)","NSP12, NSP7, NSP8, ...",FALSE
"183","5R8T","PANDDA ANALYSIS GROUP DEPOSITION OF GROUND-STATE MODEL OF SARS-COV-2 MAIN PROTEASE SCREENED AGAINST DSI POISED (ENAMINE), FRAGLITES AND PEPLITES (NEWCASTLE UNIVERSITY), MINI FRAGS (ASTEX), YORK 3D (YORK UNIVERSITY), ELECTROPHILE CYSTEINE COVALENT (WEIZMAN INSTITUTE) FRAGMENT LIBRARIES","X-RAY DIFFRACTION (1.27 Å)","3C-like proteinase, DIMETHYL SULFOXIDE",FALSE
"184","6M71","SARS-COV-2 RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH COFACTORS","ELECTRON MICROSCOPY (2.9 Å)","SARS-Cov-2 NSP 12, SARS-Cov-2 NSP 7, SARS-Cov-2 NSP 8",TRUE
"185","6W9C","THE CRYSTAL STRUCTURE OF PAPAIN-LIKE PROTEASE OF SARS COV-2","X-RAY DIFFRACTION (2.7 Å)","Papain-like proteinase, ZINC ION, CHLORIDE ION",TRUE
"186","5REJ","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102241","X-RAY DIFFRACTION (1.72 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(thiophen-2-yl)sulfonyl]piperazin-1-yl}ethan-1-one",FALSE
"187","5REA","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z31432226","X-RAY DIFFRACTION (1.63 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, (azepan-1-yl)(2H-1,3-benzodioxol-5-yl)methanone",FALSE
"188","5RE9","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z2856434836","X-RAY DIFFRACTION (1.72 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 2-(4-methylphenoxy)-1-(4-methylpiperazin-4-ium-1-yl)ethanone",FALSE
"189","5RF1","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH NCL-00023830","X-RAY DIFFRACTION (1.73 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 4-bromobenzene-1-sulfonamide",FALSE
"190","5REE","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z2217052426","X-RAY DIFFRACTION (1.77 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, (2R,3R)-1-benzyl-2-methylpiperidin-3-ol",FALSE
"191","5RF2","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1741969146","X-RAY DIFFRACTION (1.53 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-azanylpropylideneazanium",FALSE
"192","5RFT","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102432","X-RAY DIFFRACTION (1.58 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[(4S)-4-phenyl-3,4-dihydroisoquinolin-2(1H)-yl]ethan-1-one",FALSE
"193","5RFK","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102575","X-RAY DIFFRACTION (1.75 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-(1-acetylpiperidin-4-yl)benzamide",FALSE
"194","6W63","STRUCTURE OF COVID-19 MAIN PROTEASE BOUND TO POTENT BROAD-SPECTRUM NON-COVALENT INHIBITOR X77","X-RAY DIFFRACTION (2.1 Å)","3C-like proteinase, N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide",FALSE
"195","5RFD","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z126932614","X-RAY DIFFRACTION (1.41 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 2-[(methylsulfonyl)methyl]-1H-benzimidazole",FALSE
"196","5REU","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102395","X-RAY DIFFRACTION (1.69 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 2-[(4-acetylpiperazin-1-yl)sulfonyl]benzonitrile",FALSE
"197","5REB","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z2856434899","X-RAY DIFFRACTION (1.68 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[(thiophen-3-yl)methyl]piperidin-4-ol",FALSE
"198","6W6Y","CRYSTAL STRUCTURE OF ADP RIBOSE PHOSPHATASE OF NSP3 FROM SARS COV-2 IN COMPLEX WITH AMP","X-RAY DIFFRACTION (1.451 Å)","Non-structural protein 3, ADENOSINE MONOPHOSPHATE, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID",FALSE
"199","5RG0","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102535","X-RAY DIFFRACTION (1.72 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1,1'-(piperazine-1,4-diyl)di(ethan-1-one)",FALSE
"200","5REY","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102911","X-RAY DIFFRACTION (1.96 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(2-methylphenyl)methyl]-1,4-diazepan-1-yl}ethan-1-one",FALSE
"201","5REH","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z111507846","X-RAY DIFFRACTION (1.8 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-cyclohexyl-3-(2-pyridin-4-ylethyl)urea",FALSE
"202","5RF8","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z271004858","X-RAY DIFFRACTION (1.44 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 4-amino-N-(pyridin-2-yl)benzenesulfonamide",FALSE
"203","5RE8","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z2737076969","X-RAY DIFFRACTION (1.81 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-(3-fluorophenyl)-N-[(furan-2-yl)methyl]methanamine",FALSE
"204","5REL","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102340","X-RAY DIFFRACTION (1.62 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(3-methylphenyl)methyl]piperazin-1-yl}ethan-1-one",FALSE
"205","5RFA","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z2643472210","X-RAY DIFFRACTION (1.52 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-methyl-N-{[(2S)-oxolan-2-yl]methyl}-1H-pyrazole-3-carboxamide",FALSE
"206","6W75","1.95 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF NSP10 - NSP16 COMPLEX FROM SARS-COV-2","X-RAY DIFFRACTION (1.951 Å)","SARS-CoV-2 NSP16, SARS-CoV-2 NSP10, SODIUM ION, ...",FALSE
"207","5RE7","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z30932204","X-RAY DIFFRACTION (1.79 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(4-sulfamoylphenyl)methyl]acetamide",FALSE
"208","5RFU","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102121","X-RAY DIFFRACTION (1.53 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(5-chlorothiophen-2-yl)sulfonyl]piperazin-1-yl}ethan-1-one",FALSE
"209","5REW","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102275","X-RAY DIFFRACTION (1.55 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(1R)-1-(naphthalen-1-yl)ethyl]acetamide",FALSE
"210","5RE4","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1129283193","X-RAY DIFFRACTION (1.88 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-(4-methylpyridin-3-yl)acetamide",FALSE
"211","5RFI","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102353","X-RAY DIFFRACTION (1.69 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(2,5-dimethylphenyl)sulfonyl]piperazin-1-yl}ethan-1-one",FALSE
"212","5RFJ","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0103067","X-RAY DIFFRACTION (1.8 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-(4-methoxy-1,3-benzothiazol-2-yl)acetamide",FALSE
"213","5RFS","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102739","X-RAY DIFFRACTION (1.7 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(thiophen-3-yl)methyl]piperazin-1-yl}ethan-1-one",FALSE
"214","5RFG","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102372","X-RAY DIFFRACTION (2.32 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(3S)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-phenylacetamide",FALSE
"215","5RER","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102615","X-RAY DIFFRACTION (1.88 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[(2R)-2-(4-fluorophenyl)morpholin-4-yl]ethan-1-one",FALSE
"216","5RFV","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102306","X-RAY DIFFRACTION (1.48 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[4-(thiophene-2-carbonyl)piperazin-1-yl]ethan-1-one",FALSE
"217","5RFR","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102169","X-RAY DIFFRACTION (1.71 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(5-bromothiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one",FALSE
"218","5RFB","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1271660837","X-RAY DIFFRACTION (1.48 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]ethanamine",FALSE
"219","5REK","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102327","X-RAY DIFFRACTION (1.74 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(3-fluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one",FALSE
"220","5RFF","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102704","X-RAY DIFFRACTION (1.78 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(4-chlorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one",FALSE
"221","5RF3","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1741970824","X-RAY DIFFRACTION (1.5 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, pyrimidin-5-amine",FALSE
"222","5RF6","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1348371854","X-RAY DIFFRACTION (1.45 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile",FALSE
"223","5RFZ","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102274","X-RAY DIFFRACTION (1.68 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-(2-chloropyridin-3-yl)acetamide",FALSE
"224","5RET","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102269","X-RAY DIFFRACTION (1.68 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(3-chlorophenyl)methyl]piperazin-1-yl}ethan-1-one",FALSE
"225","5REI","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z2856434856","X-RAY DIFFRACTION (1.82 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 4-[(3-chlorophenyl)methyl]morpholine",FALSE
"226","5RFQ","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102179","X-RAY DIFFRACTION (1.76 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[3-(2-oxopyrrolidin-1-yl)phenyl]acetamide",FALSE
"227","5RE6","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z54571979","X-RAY DIFFRACTION (1.87 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-{4-[(pyrimidin-2-yl)oxy]phenyl}acetamide",FALSE
"228","5RFM","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102539","X-RAY DIFFRACTION (2.06 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(3R)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-(4-methylphenyl)acetamide",FALSE
"229","5REX","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102287","X-RAY DIFFRACTION (2.07 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(naphthalen-1-yl)methyl]piperazin-1-yl}ethan-1-one",FALSE
"230","5RED","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z2856434865","X-RAY DIFFRACTION (1.47 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 4-[2-(phenylsulfanyl)ethyl]morpholine",FALSE
"231","5REC","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1587220559","X-RAY DIFFRACTION (1.73 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 2-{[(1H-benzimidazol-2-yl)amino]methyl}phenol",FALSE
"232","5RF9","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z217038356","X-RAY DIFFRACTION (1.43 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[(2~{S})-2-methylmorpholin-4-yl]-2-pyrazol-1-yl-ethanone",FALSE
"233","5RF5","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z3241250482","X-RAY DIFFRACTION (1.74 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1,1-bis(oxidanylidene)thietan-3-ol",FALSE
"234","5RFN","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102868","X-RAY DIFFRACTION (1.8 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(3R)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-(4-fluorophenyl)acetamide",FALSE
"235","5REN","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102425","X-RAY DIFFRACTION (2.15 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[(3R)-3-(1,3-benzothiazol-2-yl)piperidin-1-yl]ethan-1-one",FALSE
"236","5RF4","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1741982125","X-RAY DIFFRACTION (1.61 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, pyridin-2-ol",FALSE
"237","5RF7","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z316425948_MINOR","X-RAY DIFFRACTION (1.54 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-(4-methylpiperazin-1-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)ethan-1-one",FALSE
"238","5RFP","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102190","X-RAY DIFFRACTION (2.03 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(1S)-1-(3-chlorophenyl)ethyl]acetamide",FALSE
"239","5REZ","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH POB0129","X-RAY DIFFRACTION (1.79 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, (1R,2S)-2-(thiophen-3-yl)cyclopentane-1-carboxamide",FALSE
"240","5REG","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1545313172","X-RAY DIFFRACTION (1.67 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, (2~{S})-~{N}-(4-aminocarbonylphenyl)oxolane-2-carboxamide",FALSE
"241","6W61","CRYSTAL STRUCTURE OF THE METHYLTRANSFERASE-STIMULATORY FACTOR COMPLEX OF NSP16 AND NSP10 FROM SARS COV-2.","X-RAY DIFFRACTION (2 Å)","2'-O-methyltransferase, Non-structural protein 10, CHLORIDE ION, ...",TRUE
"242","5RFE","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z509756472","X-RAY DIFFRACTION (1.46 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide",FALSE
"243","5RE5","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z33545544","X-RAY DIFFRACTION (2.07 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N~1~-phenylpiperidine-1,4-dicarboxamide",FALSE
"244","5RFL","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102389","X-RAY DIFFRACTION (1.64 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-acetyl-N-(2-hydroxyphenyl)piperidine-4-carboxamide",FALSE
"245","5RES","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102281","X-RAY DIFFRACTION (1.65 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(2-fluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one",FALSE
"246","5REF","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z24758179","X-RAY DIFFRACTION (1.61 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, methyl 3-(methylsulfonylamino)benzoate",FALSE
"247","5RFW","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102243","X-RAY DIFFRACTION (1.43 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(thiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one",FALSE
"248","6YB7","SARS-COV-2 MAIN PROTEASE WITH UNLIGANDED ACTIVE SITE (2019-NCOV, CORONAVIRUS DISEASE 2019, COVID-19)","X-RAY DIFFRACTION (1.25 Å)","Replicase polyprotein 1ab, DIMETHYL SULFOXIDE",FALSE
"249","5REV","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0103072","X-RAY DIFFRACTION (1.6 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[3-(thiomorpholine-4-carbonyl)phenyl]acetamide",FALSE
"250","5RFX","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102254","X-RAY DIFFRACTION (1.55 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[4-(4-methoxyphenyl)piperazin-1-yl]ethan-1-one",FALSE
"251","5REM","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0103016","X-RAY DIFFRACTION (1.96 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1 1-(4-(2-nitrophenyl)piperazin-1-yl)ethan-1-one",FALSE
"252","5RF0","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH POB0073","X-RAY DIFFRACTION (1.65 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, [1-(pyridin-2-yl)cyclopentyl]methanol",FALSE
"253","5REP","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102201","X-RAY DIFFRACTION (1.81 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(2,6-difluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one",FALSE
"254","6W41","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH HUMAN ANTIBODY CR3022","X-RAY DIFFRACTION (3.084 Å)","CR3022 Fab heavy chain, CR3022 Fab light chain, Spike protein S1, ...",TRUE
"255","5REO","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102578","X-RAY DIFFRACTION (1.88 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-[(2H-1,3-benzodioxol-5-yl)methyl]acetamide",FALSE
"256","5RFH","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102277","X-RAY DIFFRACTION (1.58 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-{4-[(5-chlorothiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one",FALSE
"257","5RFC","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z979145504","X-RAY DIFFRACTION (1.4 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, methyl (2-methyl-4-phenyl-1,3-thiazol-5-yl)carbamate",FALSE
"258","5RFY","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102974","X-RAY DIFFRACTION (1.9 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-acetyl-N-methyl-N-(propan-2-yl)piperidine-4-carboxamide",FALSE
"259","5RFO","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH PCM-0102972","X-RAY DIFFRACTION (1.83 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, 1-[4-(piperidine-1-carbonyl)piperidin-1-yl]ethan-1-one",FALSE
"260","6M3M","CRYSTAL STRUCTURE OF SARS-COV-2 NUCLEOCAPSID PROTEIN N-TERMINAL RNA BINDING DOMAIN","X-RAY DIFFRACTION (2.7 Å)","SARS-CoV-2 nucleocapsid protein",TRUE
"261","6LZG","STRUCTURE OF NOVEL CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH ITS RECEPTOR ACE2","X-RAY DIFFRACTION (2.5 Å)","Angiotensin-converting enzyme 2, Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"262","6W4B","THE CRYSTAL STRUCTURE OF NSP9 RNA BINDING PROTEIN OF SARS COV-2","X-RAY DIFFRACTION (2.95 Å)","Non-structural protein 9",TRUE
"263","6M0J","CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BOUND WITH ACE2","X-RAY DIFFRACTION (2.45 Å)","Angiotensin-converting enzyme 2, Spike receptor binding domain, ZINC ION, ...",TRUE
"264","6W4H","1.80 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF NSP16 - NSP10 COMPLEX FROM SARS-COV-2","X-RAY DIFFRACTION (1.8 Å)","SARS-CoV-2 NSP16, SARS-CoV-2 NSP10, SULFITE ION, ...",TRUE
"265","6Y84","SARS-COV-2 MAIN PROTEASE WITH UNLIGANDED ACTIVE SITE (2019-NCOV, CORONAVIRUS DISEASE 2019, COVID-19)","X-RAY DIFFRACTION (1.39 Å)","Replicase polyprotein 1ab, DIMETHYL SULFOXIDE",FALSE
"266","6VXX","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN (CLOSED STATE)","ELECTRON MICROSCOPY (2.8 Å)","SARS-CoV-2 spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"267","5R82","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH Z219104216","X-RAY DIFFRACTION (1.31 Å)","3C-like proteinase, 6-(ethylamino)pyridine-3-carbonitrile, DIMETHYL SULFOXIDE",FALSE
"268","5R84","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH Z31792168","X-RAY DIFFRACTION (1.83 Å)","3C-like proteinase, 2-cyclohexyl-~{N}-pyridin-3-yl-ethanamide, DIMETHYL SULFOXIDE",FALSE
"269","6M17","THE 2019-NCOV RBD/ACE2-B0AT1 COMPLEX","ELECTRON MICROSCOPY (2.9 Å)","Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2, SARS-coV-2 Receptor Binding Domain, ...",TRUE
"270","6VYO","CRYSTAL STRUCTURE OF RNA BINDING DOMAIN OF NUCLEOCAPSID PHOSPHOPROTEIN FROM SARS CORONAVIRUS 2","X-RAY DIFFRACTION (1.7 Å)","Nucleoprotein, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, CHLORIDE ION, ...",TRUE
"271","5R81","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH Z1367324110","X-RAY DIFFRACTION (1.95 Å)","3C-like proteinase, 1-methyl-3,4-dihydro-2~{H}-quinoline-7-sulfonamide, DIMETHYL SULFOXIDE",FALSE
"272","5R7Z","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z1220452176","X-RAY DIFFRACTION (1.59 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, ~{N}-[2-(5-fluoranyl-1~{H}-indol-3-yl)ethyl]ethanamide",FALSE
"273","6W02","CRYSTAL STRUCTURE OF ADP RIBOSE PHOSPHATASE OF NSP3 FROM SARS COV-2 IN THE COMPLEX WITH ADP RIBOSE","X-RAY DIFFRACTION (1.5 Å)","Non-structural protein 3, ADENOSINE-5-DIPHOSPHORIBOSE, 1,2-ETHANEDIOL",FALSE
"274","6M03","THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN APO FORM","X-RAY DIFFRACTION (2 Å)","main protease",FALSE
"275","5R80","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z18197050","X-RAY DIFFRACTION (1.93 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, methyl 4-sulfamoylbenzoate",FALSE
"276","5RM8","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z1614545742","X-RAY DIFFRACTION (2.143 Å)","Helicase, methyl (2~{S},4~{R})-1-(furan-2-ylcarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylate, ZINC ION, ...",FALSE
"277","5RMG","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z285675722","X-RAY DIFFRACTION (2.115 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"278","5RMI","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z53860899","X-RAY DIFFRACTION (2.116 Å)","Helicase, ~{N}-(1,3-benzodioxol-5-ylmethyl)ethanesulfonamide, ZINC ION, ...",FALSE
"279","5RLC","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z56923284","X-RAY DIFFRACTION (1.92 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"280","5RLV","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z2467208649","X-RAY DIFFRACTION (2.21 Å)","Helicase, N-(propan-2-yl)-1H-benzimidazol-2-amine, ZINC ION, ...",FALSE
"281","5RLK","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z1509882419","X-RAY DIFFRACTION (1.956 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"282","5RLS","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z59181945","X-RAY DIFFRACTION (2.278 Å)","Helicase, N-hydroxyquinoline-2-carboxamide, ZINC ION, ...",FALSE
"283","5RLH","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z2856434778","X-RAY DIFFRACTION (2.379 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"284","5RLN","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z364328788","X-RAY DIFFRACTION (2.147 Å)","Helicase, 3-(acetylamino)-4-fluorobenzoic acid, ZINC ION, ...",FALSE
"285","5RM2","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z1741964527","X-RAY DIFFRACTION (1.82 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"286","5RM1","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z426041412","X-RAY DIFFRACTION (1.896 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"287","6ZB4","SARS COV-2 SPIKE PROTEIN, CLOSED CONFORMATION, C1 SYMMETRY","ELECTRON MICROSCOPY (3.03 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose, ...",FALSE
"288","5RMA","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z321318226","X-RAY DIFFRACTION (1.89 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"289","5RML","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z85956652","X-RAY DIFFRACTION (2.43 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"290","5RMD","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z57614330","X-RAY DIFFRACTION (1.92 Å)","Helicase, N-ethyl-4-[(methylsulfonyl)amino]benzamide, ZINC ION, ...",FALSE
"291","5RMJ","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z68299550","X-RAY DIFFRACTION (2.1 Å)","Helicase, 3-chloro-N-(1-hydroxy-2-methylpropan-2-yl)benzamide, ZINC ION, ...",FALSE
"292","5RLI","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z45617795","X-RAY DIFFRACTION (2.26 Å)","Helicase, N-(2-phenylethyl)methanesulfonamide, ZINC ION, ...",FALSE
"293","7CWB","AMBIENT-TEMPERATURE SERIAL FEMTOSECOND X-RAY CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE AT 1.9 A RESOLUTION (C121)","X-RAY DIFFRACTION (1.9 Å)","3C-like proteinase",FALSE
"294","5RLO","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z1454310449","X-RAY DIFFRACTION (2.097 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"295","5RMC","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z24758179","X-RAY DIFFRACTION (2.15 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"296","7K3N","CRYSTAL STRUCTURE OF NSP1 FROM SARS-COV-2","X-RAY DIFFRACTION (1.65 Å)","Host translation inhibitor nsp1",TRUE
"297","5RM9","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z2856434942","X-RAY DIFFRACTION (2.076 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"298","7K6D","SARS-COV-2 MAIN PROTEASE CO-CRYSTAL STRUCTURE WITH TELAPREVIR DETERMINED FROM CRYSTALS GROWN WITH 40 NL ACOUSTICALLY EJECTED MPRO DROPLETS AT 1.48 A RESOLUTION (CRYO-PROTECTED)","X-RAY DIFFRACTION (1.48 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide",FALSE
"299","5RMB","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z2856434920","X-RAY DIFFRACTION (2.206 Å)","Helicase, ethyl (1,1-dioxo-1lambda~6~,4-thiazinan-4-yl)acetate, ZINC ION, ...",FALSE
"300","6VYB","SARS-COV-2 SPIKE ECTODOMAIN STRUCTURE (OPEN STATE)","ELECTRON MICROSCOPY (3.2 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"301","5R7Y","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH Z45617795","X-RAY DIFFRACTION (1.65 Å)","3C-like proteinase, N-(2-phenylethyl)methanesulfonamide, DIMETHYL SULFOXIDE, ...",FALSE
"302","5R83","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z44592329","X-RAY DIFFRACTION (1.58 Å)","3C-like proteinase, DIMETHYL SULFOXIDE, N-phenyl-N'-pyridin-3-ylurea",FALSE
"303","6W01","THE 1.9 A CRYSTAL STRUCTURE OF NSP15 ENDORIBONUCLEASE FROM SARS COV-2 IN THE COMPLEX WITH A CITRATE","X-RAY DIFFRACTION (1.9 Å)","Uridylate-specific endoribonuclease, 1,2-ETHANEDIOL, DI(HYDROXYETHYL)ETHER, ...",FALSE
"304","6VWW","CRYSTAL STRUCTURE OF NSP15 ENDORIBONUCLEASE FROM SARS COV-2.","X-RAY DIFFRACTION (2.2 Å)","Uridylate-specific endoribonuclease, GLYCEROL, MAGNESIUM ION, ...",FALSE
"305","6Y2E","CRYSTAL STRUCTURE OF THE FREE ENZYME OF THE SARS-COV-2 (2019-NCOV) MAIN PROTEASE","X-RAY DIFFRACTION (1.75 Å)","Replicase polyprotein 1ab",FALSE
"306","6VW1","STRUCTURE OF SARS-COV-2 CHIMERIC RECEPTOR-BINDING DOMAIN COMPLEXED WITH ITS RECEPTOR HUMAN ACE2","X-RAY DIFFRACTION (2.68 Å)","Angiotensin-converting enzyme 2, SARS-CoV-2 chimeric RBD, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"307","6Y2F","CRYSTAL STRUCTURE (MONOCLINIC FORM) OF THE COMPLEX RESULTING FROM THE REACTION BETWEEN SARS-COV-2 (2019-NCOV) MAIN PROTEASE AND TERT-BUTYL (1-((S)-1-(((S)-4-(BENZYLAMINO)-3,4-DIOXO-1-((S)-2-OXOPYRROLIDIN-3-YL)BUTAN-2-YL)AMINO)-3-CYCLOPROPYL-1-OXOPROPAN-2-YL)-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)CARBAMATE (ALPHA-KETOAMIDE 13B)","X-RAY DIFFRACTION (1.95 Å)","Replicase polyprotein 1ab, DIMETHYL SULFOXIDE, ~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",FALSE
"308","6Y2G","CRYSTAL STRUCTURE (ORTHORHOMBIC FORM) OF THE COMPLEX RESULTING FROM THE REACTION BETWEEN SARS-COV-2 (2019-NCOV) MAIN PROTEASE AND TERT-BUTYL (1-((S)-1-(((S)-4-(BENZYLAMINO)-3,4-DIOXO-1-((S)-2-OXOPYRROLIDIN-3-YL)BUTAN-2-YL)AMINO)-3-CYCLOPROPYL-1-OXOPROPAN-2-YL)-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)CARBAMATE (ALPHA-KETOAMIDE 13B)","X-RAY DIFFRACTION (2.2 Å)","Replicase polyprotein 1ab, GLYCINE, ~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate",FALSE
"309","6VXS","CRYSTAL STRUCTURE OF ADP RIBOSE PHOSPHATASE OF NSP3 FROM SARS COV-2","X-RAY DIFFRACTION (2.03 Å)","Non-structural protein 3, SULFATE ION, 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID, ...",FALSE
"310","6LXT","STRUCTURE OF POST FUSION CORE OF 2019-NCOV S2 SUBUNIT","X-RAY DIFFRACTION (2.9 Å)","Spike protein S2, TETRAETHYLENE GLYCOL, ZINC ION",TRUE
"311","6VSB","PREFUSION 2019-NCOV SPIKE GLYCOPROTEIN WITH A SINGLE RECEPTOR-BINDING DOMAIN UP","ELECTRON MICROSCOPY (3.46 Å)","SARS-CoV-2 spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"312","6LVN","STRUCTURE OF THE 2019-NCOV HR2 DOMAIN","X-RAY DIFFRACTION (2.47 Å)","Spike protein S2",TRUE
"313","6LU7","THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR N3","X-RAY DIFFRACTION (2.16 Å)","main protease, N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE",FALSE
"314","5RM7","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z69118333","X-RAY DIFFRACTION (1.84 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"315","5RME","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z26333434","X-RAY DIFFRACTION (2.23 Å)","Helicase, 4-(benzimidazol-1-ylmethyl)benzenecarbonitrile, ZINC ION, ...",FALSE
"316","5RLL","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z425387594","X-RAY DIFFRACTION (2.08 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"317","5RLU","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z744754722","X-RAY DIFFRACTION (2.347 Å)","Helicase, 2-(thiophen-2-yl)-1H-imidazole, ZINC ION, ...",FALSE
"318","7K3G","SARS-COV-2 ENVELOPE PROTEIN TRANSMEMBRANE DOMAIN: PENTAMERIC STRUCTURE DETERMINED BY SOLID-STATE NMR","SOLID-STATE NMR","Envelope small membrane protein",TRUE
"319","5RL9","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z1703168683","X-RAY DIFFRACTION (1.788 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",TRUE
"320","5RM3","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z1745658474","X-RAY DIFFRACTION (2.09 Å)","Helicase, 2-(trifluoromethyl)pyrimidine-5-carboxamide, ZINC ION, ...",FALSE
"321","5RMH","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z1101755952","X-RAY DIFFRACTION (2.021 Å)","Helicase, [(4S)-4-methylazepan-1-yl](1,3-thiazol-4-yl)methanone, ZINC ION, ...",FALSE
"322","5RMK","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z1273312153","X-RAY DIFFRACTION (2.08 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"323","5RLP","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z166605480","X-RAY DIFFRACTION (2.562 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"324","5RL7","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z364321922","X-RAY DIFFRACTION (1.89 Å)","Helicase, 5-(acetylamino)-2-fluorobenzoic acid, ZINC ION, ...",FALSE
"325","5RLF","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z235341991","X-RAY DIFFRACTION (2.235 Å)","Helicase, N-(2-methoxy-5-methylphenyl)glycinamide, ZINC ION, ...",FALSE
"326","5RM6","PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 HELICASE IN COMPLEX WITH Z396380540","X-RAY DIFFRACTION (2.128 Å)","Helicase, ZINC ION, PHOSPHATE ION, ...",FALSE
"327","7CAI","SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB","ELECTRON MICROSCOPY (3.49 Å)","Spike glycoprotein, Light chain of H014 Fab, Heavy chain of H014 Fab, ...",TRUE
"328","7CAK","SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB","ELECTRON MICROSCOPY (3.58 Å)","Spike glycoprotein, Light chain of H014 Fab, Heavy chain of H014 Fab, ...",FALSE
"329","7JX6","STRUCTURE OF THE SARS-COV-2 ORF8 ENCODED ACCESSORY PROTEIN","X-RAY DIFFRACTION (1.61 Å)","ORF8 protein, SODIUM ION",TRUE
"330","7JZU","SARS-COV-2 SPIKE IN COMPLEX WITH LCB1 (LOCAL REFINEMENT OF THE RBD AND LCB1)","ELECTRON MICROSCOPY (3.1 Å)","LCB1, Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"331","7K1L","CRYSTAL STRUCTURE OF NSP15 ENDORIBONUCLEASE FROM SARS COV-2 IN THE COMPLEX WITH URIDINE-2',3'-VANADATE","X-RAY DIFFRACTION (2.25 Å)","Uridylate-specific endoribonuclease, URIDINE-2',3'-VANADATE, ACETATE ION, ...",FALSE
"332","7JZL","SARS-COV-2 SPIKE IN COMPLEX WITH LCB1 (2RBDS OPEN)","ELECTRON MICROSCOPY (2.7 Å)","Spike glycoprotein, LCB1, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"333","7AAP","NSP7-NSP8-NSP12 SARS-COV2 RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH TEMPLATE:PRIMER DSRNA AND FAVIPIRAVIR-RTP","ELECTRON MICROSCOPY (2.6 Å)","Non-structural protein 12, Non-structural protein 8, Non-structural protein 7, ...",TRUE
"334","7A98","SARS-COV-2 SPIKE GLYCOPROTEIN WITH 3 ACE2 BOUND","ELECTRON MICROSCOPY (5.4 Å)","Spike glycoprotein, Angiotensin-converting enzyme 2",FALSE
"335","7D1O","CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE WITH NARLAPREVIR","X-RAY DIFFRACTION (1.78 Å)","3C-like proteinase, (1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-{(1S)-1-[(1R)-2-(cyclopropyla mino)-1-hydroxy-2-oxoethyl]pentyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",FALSE
"336","7K40","CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE (3CLPRO/MPRO) IN COMPLEX WITH COVALENT INHIBITOR BOCEPREVIR AT 1.35 A RESOLUTION","X-RAY DIFFRACTION (1.35 Å)","3C-like proteinase, boceprevir (bound form), DIMETHYL SULFOXIDE",FALSE
"337","7K1O","CRYSTAL STRUCTURE OF NSP15 ENDORIBONUCLEASE FROM SARS COV-2 IN THE COMPLEX WITH URIDINE-3',5'-DIPHOSPHATE","X-RAY DIFFRACTION (2.4 Å)","Uridylate-specific endoribonuclease, 1-(3,5-di-O-phosphono-alpha-L-xylofuranosyl)pyrimidine-2,4(1H,3H)-dione, 1,2-ETHANEDIOL",FALSE
"338","6ZXN","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING NANOBODIES (TY1)","ELECTRON MICROSCOPY (2.93 Å)","Spike glycoprotein, Nanobody Ty1, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"339","7JZN","SARS-COV-2 SPIKE IN COMPLEX WITH LCB3 (2RBDS OPEN)","ELECTRON MICROSCOPY (3.1 Å)","Spike glycoprotein, LCB3, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"340","7JKV","CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR GRL-2420","X-RAY DIFFRACTION (1.25 Å)","3C-like proteinase, N-[(2S)-1-({(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide, PENTAETHYLENE GLYCOL",TRUE
"341","7JZM","SARS-COV-2 SPIKE IN COMPLEX WITH LCB3 (LOCAL REFINEMENT OF THE RBD AND LCB3)","ELECTRON MICROSCOPY (3.5 Å)","LCB3, Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"342","7K3T","CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE (3CLPRO/MPRO) IN THE APO FORM AT 1.2 A RESOLUTION","X-RAY DIFFRACTION (1.2 Å)","3C-like proteinase, DIMETHYL SULFOXIDE",FALSE
"343","7CHC","CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB","X-RAY DIFFRACTION (2.71 Å)","BD-629 Fab H, IGK@ protein, Spike glycoprotein, ...",TRUE
"344","7A97","SARS-COV-2 SPIKE GLYCOPROTEIN WITH 2 ACE2 BOUND","ELECTRON MICROSCOPY (4.4 Å)","Spike glycoprotein, Angiotensin-converting enzyme 2",FALSE
"345","7CHE","CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB","X-RAY DIFFRACTION (3.416 Å)","BD-236 Fab heavy chain, BD-236 Fab light chain, SARS-coV-2 Receptor Binding Domain, ...",TRUE
"346","7A5S","COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT)","ELECTRON MICROSCOPY (3.9 Å)","CR3022 Fab Heavy Chain, CR3022 Fab Light Chain, Spike glycoprotein, ...",TRUE
"347","7JZ0","CRYSTAL STRUCTURE OF SARS-COV-2 NSP16/10 HETERODIMER IN COMPLEX WITH (M7GPPPA2M)PUPUPAPAPA (CAP-1) AND S-ADENOSYL-L-HOMOCYSTEINE (SAH).","X-RAY DIFFRACTION (2.15 Å)","2'-O-methyltransferase, Non-structural protein 10, RNA (5'-D(*(M7G))-R(P*(A2M)P*UP*U)-3'), ...",FALSE
"348","7A91","DISSOCIATED S1 DOMAIN OF SARS-COV-2 SPIKE BOUND TO ACE2 (NON-UNIFORM REFINEMENT)","ELECTRON MICROSCOPY (3.6 Å)","Angiotensin-converting enzyme 2, Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"349","7CX9","CRYSTAL STRUCTURE OF THE SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH INZ-1","X-RAY DIFFRACTION (1.73 Å)","3C protein, 3-iodanyl-1~{H}-indazole-7-carbaldehyde, GLYCEROL, ...",FALSE
"350","7CHF","CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB","X-RAY DIFFRACTION (2.674 Å)","BD-604 Fab heavy chain, BD-604 Fab light chain, SARS-coV-2 Receptor Binding Domain, ...",TRUE
"351","7JYY","CRYSTAL STRUCTURE OF SARS-COV-2 NSP16/10 HETERODIMER IN COMPLEX WITH (M7GPPPA)PUPUPAPAPA (CAP-0) AND S-ADENOSYLMETHIONINE (SAM).","X-RAY DIFFRACTION (2.05 Å)","2'-O-methyltransferase, Non-structural protein 10, RNA (5'-D(*(M7G))-R(P*AP*UP*UP*A)-3'), ...",TRUE
"352","7A94","SARS-COV-2 SPIKE GLYCOPROTEIN WITH 1 ACE2 BOUND","ELECTRON MICROSCOPY (3.9 Å)","Spike glycoprotein, Angiotensin-converting enzyme 2, 2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"353","7A93","SARS-COV-2 SPIKE GLYCOPROTEIN WITH 2 RBDS ERECT","ELECTRON MICROSCOPY (5.9 Å)","Spike glycoprotein",FALSE
"354","7A5R","COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT)","ELECTRON MICROSCOPY (3.7 Å)","CR3022 Fab Heavy Chain, CR3022 Fab Light Chain, Spike glycoprotein, ...",TRUE
"355","7A95","SARS-COV-2 SPIKE GLYCOPROTEIN WITH 1 ACE2 BOUND AND 1 RBD ERECT IN CLOCKWISE DIRECTION","ELECTRON MICROSCOPY (4.3 Å)","Spike glycoprotein, Angiotensin-converting enzyme 2",FALSE
"356","7CH4","CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-604 FAB","X-RAY DIFFRACTION (3.15 Å)","BD-604 Fab H, BD-604 Fab L, Spike glycoprotein",TRUE
"357","7A96","SARS-COV-2 SPIKE GLYCOPROTEIN WITH 1 ACE2 BOUND AND 1 RBD ERECT IN ANTICLOCKWISE DIRECTION","ELECTRON MICROSCOPY (4.8 Å)","Spike glycoprotein, Angiotensin-converting enzyme 2",FALSE
"358","7CHH","CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS","ELECTRON MICROSCOPY (3.49 Å)","Spike glycoprotein, BD-368-2 Fab heavy chain, BD-368-2 Fab light chain, ...",TRUE
"359","7JVZ","SARS COV-2 MAIN PROTEASE 3CLPRO, ROOM TEMPERATURE, DAMAGE FREE XFEL MONOCLINIC STRUCTURE","X-RAY DIFFRACTION (2.5 Å)","3C-like proteinase",FALSE
"360","7CHB","CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB","X-RAY DIFFRACTION (2.4 Å)","BD-236 Fab heavy chain, BD-236 Fab light chain, SARS-coV-2 Receptor Binding Domain, ...",TRUE
"361","7JYC","CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE (3CLPRO/MPRO) IN COMPLEX WITH COVALENT INHIBITOR NARLAPREVIR","X-RAY DIFFRACTION (1.79 Å)","3C-like proteinase, (1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-{(1S)-1-[(1R)-2-(cyclopropyla mino)-1-hydroxy-2-oxoethyl]pentyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, DIMETHYL SULFOXIDE, ...",FALSE
"362","7JU7","THE CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH MASITINIB","X-RAY DIFFRACTION (1.6 Å)","3C-like proteinase, Masitinib, DIMETHYL SULFOXIDE, ...",FALSE
"363","6XF6","CRYO-EM STRUCTURE OF A BIOTINYLATED SARS-COV-2 SPIKE PROBE IN THE PREFUSION STATE (1 RBD UP)","ELECTRON MICROSCOPY (4 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",FALSE
"364","7C2Y","THE CRYSTAL STRUCTURE OF COVID-2019 MAIN PROTEASE IN THE APO STATE","X-RAY DIFFRACTION (1.91 Å)","3C-like proteinase",TRUE
"365","7C8B","CRYSTAL STRUCTURE OF THE SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH Z-VAD(OME)-FMK","X-RAY DIFFRACTION (2.2 Å)","3C-like proteinase, Z-VAD(OMe)-FMK, CHLORIDE ION",FALSE
"366","7C6U","CRYSTAL STRUCTURE OF SARS-COV-2 COMPLEXED WITH GC376","X-RAY DIFFRACTION (2 Å)","3C-like proteinase, (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",FALSE
"367","7CTT","CRYO-EM STRUCTURE OF FAVIPIRAVIR BOUND TO REPLICATING POLYMERASE COMPLEX OF SARS-COV-2 IN THE PRE-CATALYTIC STATE.","ELECTRON MICROSCOPY (3.2 Å)","nsp12, nsp8, nsp7, ...",TRUE
"368","7CE0","CRYSTAL STRUCTURE OF 2019-NCOV NUCLEOCAPSID C-TERMINAL DOMAIN (CTD) PROTEIN","X-RAY DIFFRACTION (1.5 Å)","Nucleoprotein",FALSE
"369","7CBT","THE CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH GC376","X-RAY DIFFRACTION (2.346 Å)","Replicase polyprotein 1ab, (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",TRUE
"370","7C2Q","THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN THE APO STATE","X-RAY DIFFRACTION (1.93 Å)","3C-like proteinase",TRUE
"371","7CDZ","CRYSTAL STRUCTURE OF 2019-NCOV NUCLEOCAPSID N-TERMINAL DOMAIN (NTD) PROTEIN","X-RAY DIFFRACTION (1.8 Å)","Nucleoprotein",FALSE
"372","7CMD","CRYSTAL STRUCTURE OF THE SARS-COV-2 PLPRO WITH GRL0617","X-RAY DIFFRACTION (2.59 Å)","Replicase polyprotein 1ab, 5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide, ZINC ION",TRUE
"373","6XF5","CRYO-EM STRUCTURE OF A BIOTINYLATED SARS-COV-2 SPIKE PROBE IN THE PREFUSION STATE (RBDS DOWN)","ELECTRON MICROSCOPY (3.45 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"374","7C8D","CRYO-EM STRUCTURE OF CAT ACE2 AND SARS-COV-2 RBD","ELECTRON MICROSCOPY (3 Å)","Angiotensin-converting enzyme 2, Spike protein S1, ZINC ION",TRUE
"375","7JME","STRUCTURE OF THE SARS-COV-2 NSP3 MACRO X DOMAIN IN COMPLEX WITH CYCLIC AMP","X-RAY DIFFRACTION (1.55 Å)","Non-structural protein 3, ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE",FALSE
"376","7CJM","SARS COV-2 PLPRO IN COMPLEX WITH GRL0617","X-RAY DIFFRACTION (3.2 Å)","Non-structural protein 3, 5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide, ZINC ION",TRUE
"377","7C6S","CRYSTAL STRUCTURE OF THE SARS-COV-2 MAIN PROTEASE COMPLEXED WITH BOCEPREVIR","X-RAY DIFFRACTION (1.6 Å)","3C-like proteinase, boceprevir (bound form)",FALSE
"378","7JMP","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-39","X-RAY DIFFRACTION (1.712 Å)","Spike protein S1, COVA2-39 heavy chain, COVA2-39 light chain, ...",TRUE
"379","7JLT","CRYSTAL STRUCTURE OF SARS-COV-2 NSP7-NSP8 COMPLEX.","X-RAY DIFFRACTION (2.7 Å)","Non-structural protein 7, Non-structural protein 8",TRUE
"380","7JHE","ROOM TEMPERATURE STRUCTURE OF SARS-COV-2 NSP10/NSP16 METHYLTRANSFERASE IN A COMPLEX WITH 2'-O-METHYLATED M7GPPPA CAP-1 AND SAH DETERMINED BY FIXED-TARGET SERIAL CRYSTALLOGRAPHY","X-RAY DIFFRACTION (2.25 Å)","2'-O-methyltransferase, Non-structural protein 10, CHLORIDE ION, ...",FALSE
"381","7JTL","STRUCTURE OF SARS-COV-2 ORF8 ACCESSORY PROTEIN","X-RAY DIFFRACTION (2.04 Å)","Nonstructural protein NS8",TRUE
"382","7CN9","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE ECTODOMAIN","ELECTRON MICROSCOPY (4.7 Å)","Spike protein S1, Spike protein S2, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"383","7JJI","STRUCTURE OF SARS-COV-2 3Q-2P FULL-LENGTH PREFUSION SPIKE TRIMER (C3 SYMMETRY)","ELECTRON MICROSCOPY (3.6 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"384","6W79","STRUCTURE OF SARS-COV MAIN PROTEASE BOUND TO POTENT BROAD-SPECTRUM NON-COVALENT INHIBITOR X77","X-RAY DIFFRACTION (1.46 Å)","Main protease, DIMETHYL SULFOXIDE, N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide, ...",TRUE
"385","7JMO","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-04","X-RAY DIFFRACTION (2.359 Å)","Spike protein S1, COVA2-04 heavy chain, COVA2-04 light chain, ...",TRUE
"386","7JIB","ROOM TEMPERATURE CRYSTAL STRUCTURE OF NSP10/NSP16 FROM SARS-COV-2 WITH SUBSTRATES AND PRODUCTS OF 2'-O-METHYLATION OF THE CAP-1","X-RAY DIFFRACTION (2.65 Å)","2'-O-methyltransferase, Non-structural protein 10, CHLORIDE ION, ...",FALSE
"387","7JRN","CRYSTAL STRUCTURE OF THE WILD TYPE SARS-COV-2 PAPAIN-LIKE PROTEASE (PLPRO) WITH INHIBITOR GRL0617","X-RAY DIFFRACTION (2.48 Å)","Papain-like proteinase, 5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide, ZINC ION, ...",TRUE
"388","7JR3","SARS-COV-2 3CL PROTEASE CRYSTALLIZED UNDER REDUCING CONDITIONS","X-RAY DIFFRACTION (1.55 Å)","3C-like proteinase",FALSE
"389","7JJJ","STRUCTURE OF SARS-COV-2 3Q-2P FULL-LENGTH DIMERS OF SPIKE TRIMERS","ELECTRON MICROSCOPY (4.5 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ...",FALSE
"390","6XRZ","THE 28-KDA FRAMESHIFT STIMULATION ELEMENT FROM THE SARS-COV-2 RNA GENOME","ELECTRON MICROSCOPY (6.9 Å)","Frameshift Stimulation Element from the SARS-CoV-2 RNA Genome",TRUE
"391","6ZMO","SARS-COV-2 NSP1 BOUND TO THE HUMAN LYAR-80S-EEF1A RIBOSOME COMPLEX","ELECTRON MICROSCOPY (3.1 Å)","28S ribosomal RNA, 5S ribosomal RNA, 5.8S ribosomal RNA, ...",TRUE
"392","6ZMT","SARS-COV-2 NSP1 BOUND TO A PRE-40S-LIKE RIBOSOME COMPLEX","ELECTRON MICROSCOPY (3 Å)","40S ribosomal protein SA, 40S ribosomal protein S3a, 40S ribosomal protein S2, ...",TRUE
"393","6ZMI","SARS-COV-2 NSP1 BOUND TO THE HUMAN LYAR-80S RIBOSOME COMPLEX","ELECTRON MICROSCOPY (2.6 Å)","28S ribosomal RNA, 5S ribosomal RNA, 5.8S ribosomal RNA, ...",TRUE
"394","6X79","PREFUSION SARS-COV-2 S ECTODOMAIN TRIMER COVALENTLY STABILIZED IN THE CLOSED CONFORMATION","ELECTRON MICROSCOPY (2.9 Å)","SARS-CoV-2 spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"395","7COM","CRYSTAL STRUCTURE OF THE SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH BOCEPREVIR (SPACE GROUP P212121)","X-RAY DIFFRACTION (2.25 Å)","main protease, boceprevir (bound form)",FALSE
"396","6XR3","X-RAY STRUCTURE OF SARS-COV-2 MAIN PROTEASE BOUND TO GRL-024-20 AT 1.45 A","X-RAY DIFFRACTION (1.45 Å)","3C-like proteinase, N-[(2S)-1-({(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",FALSE
"397","6ZRT","CRYSTAL STRUCTURE OF SARS COV2 MAIN PROTEASE IN COMPLEX WITH INHIBITOR TELAPREVIR","X-RAY DIFFRACTION (2.1 Å)","Main Protease, DIMETHYL SULFOXIDE, (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide",FALSE
"398","7JN2","THE CRYSTAL STRUCTURE OF PAPAIN-LIKE PROTEASE OF SARS COV-2 IN COMPLEX WITH PLP_SNYDER441","X-RAY DIFFRACTION (1.93 Å)","Papain-Like Protease, 3-amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide, ZINC ION, ...",FALSE
"399","6ZME","SARS-COV-2 NSP1 BOUND TO THE HUMAN CCDC124-80S-EERF1 RIBOSOME COMPLEX","ELECTRON MICROSCOPY (3 Å)","28S ribosomal RNA, 5S ribosomal RNA, 5.8S ribosomal RNA, ...",TRUE
"400","6ZRU","CRYSTAL STRUCTURE OF SARS COV2 MAIN PROTEASE IN COMPLEX WITH INHIBITOR BOCEPREVIR","X-RAY DIFFRACTION (2.1 Å)","Main Protease, DIMETHYL SULFOXIDE, boceprevir (bound form)",FALSE
"401","7CAH","THE INTERFACE OF H014 FAB BINDS TO SARS-COV-2 S","ELECTRON MICROSCOPY (3.9 Å)","Light chain of H014 Fab, Heavy chain of H014 Fab, Spike glycoprotein",TRUE
"402","6XM4","STRUCTURE OF SARS-COV-2 SPIKE AT PH 5.5, SINGLE RBD UP, CONFORMATION 2","ELECTRON MICROSCOPY (2.9 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",FALSE
"403","6XLU","STRUCTURE OF SARS-COV-2 SPIKE AT PH 4.0","ELECTRON MICROSCOPY (2.4 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"404","6XM0","CONSENSUS STRUCTURE OF SARS-COV-2 SPIKE AT PH 5.5","ELECTRON MICROSCOPY (2.7 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",FALSE
"405","6XM3","STRUCTURE OF SARS-COV-2 SPIKE AT PH 5.5, SINGLE RBD UP, CONFORMATION 1","ELECTRON MICROSCOPY (2.9 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",FALSE
"406","7JIW","THE CRYSTAL STRUCTURE OF PAPAIN-LIKE PROTEASE OF SARS COV-2 IN COMPLEX WITH PLP_SNYDER530","X-RAY DIFFRACTION (2.3 Å)","Papain-Like Protease, 5-(acryloylamino)-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide, ZINC ION, ...",FALSE
"407","7JIV","THE CRYSTAL STRUCTURE OF PAPAIN-LIKE PROTEASE OF SARS COV-2 , C111S MUTANT, IN COMPLEX WITH PLP_SNYDER530","X-RAY DIFFRACTION (2.05 Å)","Papain-like protease, 5-(acryloylamino)-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide, ZINC ION, ...",FALSE
"408","7JIR","THE CRYSTAL STRUCTURE OF PAPAIN-LIKE PROTEASE OF SARS COV-2 , C111S MUTANT, IN COMPLEX WITH PLP_SNYDER457","X-RAY DIFFRACTION (2.09 Å)","Papain-like protease, 5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide, ZINC ION, ...",FALSE
"409","6WC1","PEPTIDE-BOUND SARS-COV-2 NSP9 RNA-REPLICASE","X-RAY DIFFRACTION (2.4 Å)","SARS-coV-2 Non-structural protein 9, SULFATE ION",FALSE
"410","7JIT","THE CRYSTAL STRUCTURE OF PAPAIN-LIKE PROTEASE OF SARS COV-2 , C111S MUTANT, IN COMPLEX WITH PLP_SNYDER495","X-RAY DIFFRACTION (1.95 Å)","Papain-like protease, 5-[(carbamoylcarbamoyl)amino]-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide, ZINC ION, ...",FALSE
"411","6ZWV","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE PROTEINS ON INTACT VIRIONS: 3 CLOSED RBDS","ELECTRON MICROSCOPY (3.5 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"412","6ZN5","SARS-COV-2 NSP1 BOUND TO A PRE-40S-LIKE RIBOSOME COMPLEX - STATE 2","ELECTRON MICROSCOPY (3.2 Å)","40S ribosomal protein SA, 40S ribosomal protein S3a, 40S ribosomal protein S2, ...",TRUE
"413","6ZOW","SARS-COV-2 SPIKE IN PREFUSION STATE","ELECTRON MICROSCOPY (3 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"414","6ZSL","CRYSTAL STRUCTURE OF THE SARS-COV-2 HELICASE AT 1.94 ANGSTROM RESOLUTION","X-RAY DIFFRACTION (1.94 Å)","SARS-CoV-2 helicase NSP13, ZINC ION, PHOSPHATE ION",TRUE
"415","6ZP4","SARS-COV-2 NSP1 BOUND TO A HUMAN 43S PREINITIATION RIBOSOME COMPLEX - STATE 2","ELECTRON MICROSCOPY (2.9 Å)","40S ribosomal protein SA, 40S ribosomal protein S3a, 40S ribosomal protein S2, ...",TRUE
"416","6XEZ","STRUCTURE OF SARS-COV-2 REPLICATION-TRANSCRIPTION COMPLEX BOUND TO NSP13 HELICASE - NSP13(2)-RTC","ELECTRON MICROSCOPY (3.5 Å)","nsp12, nsp8, nsp7, ...",TRUE
"417","6ZLW","SARS-COV-2 NSP1 BOUND TO THE HUMAN 40S RIBOSOMAL SUBUNIT","ELECTRON MICROSCOPY (2.6 Å)","40S ribosomal protein SA, 40S ribosomal protein S3a, 40S ribosomal protein S2, ...",TRUE
"418","6ZP7","SARS-COV-2 SPIKE IN PREFUSION STATE (FLEXIBILITY ANALYSIS, 1-UP OPEN CONFORMATION)","ELECTRON MICROSCOPY (3.3 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",FALSE
"419","6ZP5","SARS-COV-2 SPIKE IN PREFUSION STATE (FLEXIBILITY ANALYSIS, 1-UP CLOSED CONFORMATION)","ELECTRON MICROSCOPY (3.1 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",FALSE
"420","6ZM7","SARS-COV-2 NSP1 BOUND TO THE HUMAN CCDC124-80S-EBP1 RIBOSOME COMPLEX","ELECTRON MICROSCOPY (2.7 Å)","28S ribosomal RNA, 5S ribosomal RNA, 5.8S ribosomal RNA, ...",TRUE
"421","6XQB","SARS-COV-2 RDRP/RNA COMPLEX","ELECTRON MICROSCOPY (3.4 Å)","RNA-directed RNA polymerase, Non-structural protein 8, Non-structural protein 7, ...",TRUE
"422","6ZDG","ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB","ELECTRON MICROSCOPY (4.7 Å)","Spike glycoprotein, EY6A heavy chain, EY6A light chain, ...",FALSE
"423","6ZOK","SARS-COV-2-NSP1-40S COMPLEX, FOCUSED ON BODY","ELECTRON MICROSCOPY (2.8 Å)","18S ribosomal RNA, 40S ribosomal protein SA, 40S ribosomal protein S3a, ...",TRUE
"424","6ZON","SARS-COV-2 NSP1 BOUND TO A HUMAN 43S PREINITIATION RIBOSOME COMPLEX - STATE 1","ELECTRON MICROSCOPY (3 Å)","40S ribosomal protein SA, 40S ribosomal protein S3a, 40S ribosomal protein S2, ...",TRUE
"425","6ZHD","H11-H4 BOUND TO SPIKE","ELECTRON MICROSCOPY (3.7 Å)","Spike glycoprotein,Fibritin, Nanobody H11-H4, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"426","7C7P","CRYSTAL STRUCTURE OF THE SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH TELAPREVIR","X-RAY DIFFRACTION (1.74 Å)","main protease, (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide, CHLORIDE ION, ...",FALSE
"427","7JFQ","THE CRYSTAL STRUCTURE OF 3CL MAINPRO OF SARS-COV-2 WITH DE-OXIDIZED C145","X-RAY DIFFRACTION (1.55 Å)","3C-like proteinase, 1,2-ETHANEDIOL, FORMIC ACID",FALSE
"428","6ZBP","H11-H4 COMPLEX WITH SARS-COV-2","X-RAY DIFFRACTION (1.85 Å)","Spike glycoprotein, H11-H4, 2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"429","6XM5","STRUCTURE OF SARS-COV-2 SPIKE AT PH 5.5, ALL RBDS DOWN","ELECTRON MICROSCOPY (3.1 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",FALSE
"430","6ZOJ","SARS-COV-2-NSP1-40S COMPLEX, COMPOSITE MAP","ELECTRON MICROSCOPY (2.8 Å)","18S ribosomal RNA, 40S ribosomal protein SA, 40S ribosomal protein S3a, ...",TRUE
"431","6XRA","DISTINCT CONFORMATIONAL STATES OF SARS-COV-2 SPIKE PROTEIN","ELECTRON MICROSCOPY (3 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",FALSE
"432","6ZP0","STRUCTURE OF SARS-COV-2 SPIKE PROTEIN TRIMER (SINGLE ARG S1/S2 CLEAVAGE SITE) IN CLOSED STATE","ELECTRON MICROSCOPY (3 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"433","6XQU","EXTREME MALLEABILITY OF THE SARS-COV-2 3CL MPRO ACTIVE SITE CAVITY FACILITATES BINDING OF CLINICAL ANTIVIRALS: PROSPECTS FOR REPURPOSING EXISTING DRUGS AND RAMIFICATIONS FOR INHIBITOR DESIGN","X-RAY DIFFRACTION (2.2 Å)","3C-like proteinase, boceprevir (bound form)",FALSE
"434","6XR8","DISTINCT CONFORMATIONAL STATES OF SARS-COV-2 SPIKE PROTEIN","ELECTRON MICROSCOPY (2.9 Å)","Spike glycoprotein, alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"435","6ZOX","STRUCTURE OF DISULPHIDE-STABILIZED SARS-COV-2 SPIKE PROTEIN TRIMER (X2 DISULPHIDE-BOND MUTANT, G413C, V987C, SINGLE ARG S1/S2 CLEAVAGE SITE)","ELECTRON MICROSCOPY (3 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"436","6ZOY","STRUCTURE OF DISULPHIDE-STABILIZED SARS-COV-2 SPIKE PROTEIN TRIMER (X1 DISULPHIDE-BOND MUTANT, S383C, D985C, K986P, V987P, SINGLE ARG S1/S2 CLEAVAGE SITE) IN CLOSED STATE","ELECTRON MICROSCOPY (3.1 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"437","6XS6","SARS-COV-2 SPIKE D614G VARIANT, MINUS RBD","ELECTRON MICROSCOPY (3.7 Å)","Spike glycoprotein",TRUE
"438","6ZP1","STRUCTURE OF SARS-COV-2 SPIKE PROTEIN TRIMER (K986P, V987P, SINGLE ARG S1/S2 CLEAVAGE SITE) IN CLOSED STATE","ELECTRON MICROSCOPY (3.3 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",FALSE
"439","6ZP2","STRUCTURE OF SARS-COV-2 SPIKE PROTEIN TRIMER (K986P, V987P, SINGLE ARG S1/S2 CLEAVAGE SITE) IN LOCKED STATE","ELECTRON MICROSCOPY (3.1 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"440","6XEY","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2-4","ELECTRON MICROSCOPY (3.25 Å)","SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain, ...",TRUE
"441","6XKL","SARS-COV-2 HEXAPRO S ONE RBD UP","ELECTRON MICROSCOPY (3.21 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"442","6XOA","THE CRYSTAL STRUCTURE OF 3CL MAINPRO OF SARS-COV-2 WITH C145S MUTATION","X-RAY DIFFRACTION (2.1 Å)","3C-like proteinase, 1,2-ETHANEDIOL",TRUE
"443","6XKF","THE CRYSTAL STRUCTURE OF 3CL MAINPRO OF SARS-COV-2 WITH OXIDIZED CYS145 (SULFENIC ACID CYSTEINE).","X-RAY DIFFRACTION (1.8 Å)","3C-like proteinase, 1,2-ETHANEDIOL, CHLORIDE ION",FALSE
"444","6XKM","ROOM TEMPERATURE STRUCTURE OF SARS-COV-2 NSP10/NSP16 METHYLTRANSFERASE IN A COMPLEX WITH SAM DETERMINED BY FIXED-TARGET SERIAL CRYSTALLOGRAPHY","X-RAY DIFFRACTION (2.25 Å)","2'-O-methyltransferase, Non-structural protein 10, CHLORIDE ION, ...",FALSE
"445","6XC2","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1","X-RAY DIFFRACTION (3.112 Å)","Spike protein S1, CC12.1 light chain, CC12.1 heavy chain, ...",TRUE
"446","6XMK","1.70 A RESOLUTION STRUCTURE OF SARS-COV-2 3CL PROTEASE IN COMPLEX WITH INHIBITOR 7J","X-RAY DIFFRACTION (1.7 Å)","3C-like proteinase, (1S,2S)-2-[(N-{[(4,4-difluorocyclohexyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid, TETRAETHYLENE GLYCOL",TRUE
"447","6XC7","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022","X-RAY DIFFRACTION (2.883 Å)","Spike protein S1, CR3022 heavy chain, CR3022 light chain, ...",TRUE
"448","6XC3","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022","X-RAY DIFFRACTION (2.698 Å)","CR3022 heavy chain, CR3022 light chain, CC12.1 light chain, ...",TRUE
"449","6XKH","THE 1.28A CRYSTAL STRUCTURE OF 3CL MAINPRO OF SARS-COV-2 WITH OXIDIZED C145 (SULFINIC ACID CYSTEINE)","X-RAY DIFFRACTION (1.28 Å)","3C-like proteinase, 1,2-ETHANEDIOL, FORMIC ACID, ...",FALSE
"450","6XC4","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3","X-RAY DIFFRACTION (2.341 Å)","Spike protein S1, CC12.3 heavy chain, CC12.3 light chain, ...",TRUE
"451","6XHM","COVALENT COMPLEX OF SARS-COV-2 MAIN PROTEASE WITH N-[(2S)-1-({(2S,3S)-3,4-DIHYDROXY-1-[(3S)-2-OXOPYRROLIDIN-3-YL]BUTAN-2-YL}AMINO)-4-METHYL-1-OXOPENTAN-2-YL]-4-METHOXY-1H-INDOLE-2-CARBOXAMIDE","X-RAY DIFFRACTION (1.406 Å)","3C-like proteinase, N-[(2S)-1-({(2S)-4-hydroxy-3-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide, 1,2-ETHANEDIOL",FALSE
"452","6ZFO","ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB","ELECTRON MICROSCOPY (4.4 Å)","Spike glycoprotein, EY6A heavy chain, EY6A light chain, ...",TRUE
"453","6ZCO","CRYSTAL STRUCTURE OF C-TERMINAL DIMERIZATION DOMAIN OF NUCLEOCAPSID PHOSPHOPROTEIN FROM SARS-COV-2, CRYSTAL FORM II","X-RAY DIFFRACTION (1.361 Å)","Nucleoprotein",TRUE
"454","7C2L","S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH 4A8","ELECTRON MICROSCOPY (3.1 Å)","Spike glycoprotein, heavy chain of 4A8, light chain of 4A8, ...",TRUE
"455","6XIP","THE 1.5 A CRYSTAL STRUCTURE OF THE CO-FACTOR COMPLEX OF NSP7 AND THE C-TERMINAL DOMAIN OF NSP8 FROM SARS COV-2","X-RAY DIFFRACTION (1.5 Å)","Non-structural protein 7, Non-structural protein 8, 1,2-ETHANEDIOL",TRUE
"456","6ZDH","SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB","ELECTRON MICROSCOPY (3.7 Å)","Spike glycoprotein, EY6A heavy chain, EY6A light chain, ...",TRUE
"457","6ZB5","SARS COV-2 SPIKE PROTEIN, CLOSED CONFORMATION, C3 SYMMETRY","ELECTRON MICROSCOPY (2.85 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose, ...",TRUE
"458","7K7P","STRUCTURE OF SARS-COV-2 NONSTUCTURAL PROTEIN 1","X-RAY DIFFRACTION (1.77 Å)","Non-structural protein 1",TRUE
"459","7CH5","CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB","X-RAY DIFFRACTION (2.7 Å)","BD-629 Fab H, BD-629 Fab L, Spike glycoprotein",TRUE
"460","7CJD","CRYSTAL STRUCTURE OF THE SARS-COV-2 PLPRO C111S MUTANT","X-RAY DIFFRACTION (2.501 Å)","Replicase polyprotein 1ab, ZINC ION, 1,2-ETHANEDIOL",TRUE
"461","6ZH9","TERNARY COMPLEX CR3022 H11-H4 AND RBD (SARS-COV-2)","X-RAY DIFFRACTION (3.31 Å)","CR3022 heavy, CR3022 Light chain, Spike glycoprotein, ...",TRUE
"462","6ZGE","UNCLEAVABLE SPIKE PROTEIN OF SARS-COV-2 IN CLOSED CONFORMATION","ELECTRON MICROSCOPY (2.6 Å)","Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose",TRUE
"463","6XE1","STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A POTENT NEUTRALIZING ANTIBODY, CV30 FAB","X-RAY DIFFRACTION (2.75 Å)","CV30 Fab Heavy chain, CV30 Fab Kappa chain, Spike protein S1, ...",TRUE
